23705068_1|23705068|107|#section_info|0:0|Here, we report that an mmBCFA-derived sphingolipid, d17iso-glucosylceramide, is a critical metabolite in regulating growth and development. Further analysis indicated that this lipid function is mediated by TORC1 and antagonized by the NPRL-2/3 complex in the intestine. Strikingly, the essential lipid function is bypassed by activating TORC1 or inhibiting NPRL-2/3.|#main_body|GO:0040015|negative regulation of multicellular organism growth|#go_definition|NONE|GOA|nprl-2(177532)|#gene_synonym
0.74	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_46|23705068|7551|Results|0:0|We found that in mmBCFA-deficient elo-5(-) larvae, the amount of mmBCFA-containing sphingolipids were dramatically reduced and thus asked if this mmBCFA function is mediated by a sphingolipid.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_274|23705068|51585|Materials and methods|0:0|The tat-2(-) mutations were also found to partially and temporarily suppress the lethality associated with disrupting the function of the enzyme (SPTL-1) in the first step of sphingolipid biosynthesis, suggesting a potential link between sphingolipids and mmBCFAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_196|23705068|41772|Discussion|0:0|This property is consistent with the role of this complex in repressing TOR-mediated growth regulation that was identified in budding yeast and this study.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_16|23705068|2015|abstract|0:0|TORC1 is well known for its role in sensing amino acids and growth factors, but this is the first time that it has been shown to be involved in detecting lipids.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_193|23705068|41772|Discussion|0:0|The NPRL-3 protein we identified in this pathway is conserved in all eukaryotes, and its negative regulatory role on TOR has been characterized in budding yeast (Neklesa and Davis, 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_15|23705068|2015|abstract|0:0|show that the lipid acts through a signaling pathway involving an enzyme complex called TORC1 and that the effect of the lipid can be blocked by another protein complex called NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_106|23705068|19337|Results|0:0|Taken together, our biochemical and genetic data indicate that ku540 bypasses the requirement of mmBCFAs and d17iso-GlcCer in development and does so by modifying a regulatory function downstream of d17iso-GlcCer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_127|23705068|24749|Results|0:0|Intact TORC1 function is necessary for mmBCFA-mediated growth regulation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_199|23705068|41772|Discussion|0:0|Third, the TOR pathway is down-regulated by inhibiting the abnormally high GlcCer biosynthesis in polycystic kidney disease in mouse models (Natoli et al., 2010), suggesting a possible conserved link between GlcCer and TOR activities.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_200|23705068|43359|Discussion|0:0|It is currently unknown whether an iso-branched LCB is also required for the potential role of GlcCer in mammals, given that most LCBs in mammals are straight-chain LCBs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_20|23705068|2856|abstract|0:0|thus reveals a novel regulatory function of a specific fatty acid and sphingolipid variant that is used by C. elegans to coordinate its growth and development with its metabolic status or the availability of nutrients.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_209|23705068|44224|Discussion|0:0|If such a mechanism is conserved in all animals, conceptually, d17iso-GlcCer could act as a ligand that binds to a 'receptor' to either repress the NPRL-2/3 complex or activate the TOR complex at the surface of the lysosome.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_217|23705068|45808|Discussion|0:0|Therefore, the only essential biochemical role of d17iso-GlcCer might be to activate TORC1 or repress NPRL-3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_39|23705068|6227|Introduction|0:0|It was not clear whether the essential roles of mmBCFAs and their derived lipids were due to structural requirements for animal development, as was suggested by other studies, or due to regulatory functions specific to cellular signaling processes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_178|23705068|38632|Discussion|0:0|It is conceivable that some of these functions are mediated by this GlcCer/TORC1 signaling pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_438|23705068|69114|Additional files|0:0|P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_26|23705068|3334|Introduction|0:0|While amino acids, energy, and growth factors have been described as nutrient inputs to TOR complexes, roles of lipid molecules as signals to these systems in controlling postembryonic growth and development were not known.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_40|23705068|6227|Introduction|0:0|Testing these hypotheses using model organisms is highly significant because roles of fatty acids and lipids function as nutrient signals for postembryonic development are in general poorly understood.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_43|23705068|7394|Results|0:0|A sphingolipid composed of a mmBCFA-derived long chain base mediates the essential role of mmBCFAs in the initiation of postembryonic growth and development|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_210|23705068|44224|Discussion|0:0|Alternatively, this lipid could be required for lysosome biogenesis or could be an essential constituent of the membrane microdomain that permits the proper localization or activity of TORC1 on the lysosome.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_213|23705068|44224|Discussion|0:0|One possible mechanism is that d17iso-GlcCer acts through the V-ATPase pathway, since the lysosomal V-ATPase has been shown to be stimulated by GlcCer and to play an essential role in TORC1 activation in studies using tissue culture cells (van der Poel et al., 2011; Zoncu et al., 2011; Bar-Peled et al., 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_2|23705068|107|#section_info|0:0|Here, we report that an mmBCFA-derived sphingolipid, d17iso-glucosylceramide, is a critical metabolite in regulating growth and development. Further analysis indicated that this lipid function is mediated by TORC1 and antagonized by the NPRL-2/3 complex in the intestine. Strikingly, the essential lipid function is bypassed by activating TORC1 or inhibiting NPRL-2/3.|#main_body|GO:0040015|negative regulation of multicellular organism growth|#go_definition|NONE|GOA|WBGene00018635(177532)|#gene_synonym
0.74	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_46|23705068|7551|Results|0:0|We found that in mmBCFA-deficient elo-5(-) larvae, the amount of mmBCFA-containing sphingolipids were dramatically reduced and thus asked if this mmBCFA function is mediated by a sphingolipid.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_274|23705068|51585|Materials and methods|0:0|The tat-2(-) mutations were also found to partially and temporarily suppress the lethality associated with disrupting the function of the enzyme (SPTL-1) in the first step of sphingolipid biosynthesis, suggesting a potential link between sphingolipids and mmBCFAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_196|23705068|41772|Discussion|0:0|This property is consistent with the role of this complex in repressing TOR-mediated growth regulation that was identified in budding yeast and this study.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_16|23705068|2015|abstract|0:0|TORC1 is well known for its role in sensing amino acids and growth factors, but this is the first time that it has been shown to be involved in detecting lipids.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_193|23705068|41772|Discussion|0:0|The NPRL-3 protein we identified in this pathway is conserved in all eukaryotes, and its negative regulatory role on TOR has been characterized in budding yeast (Neklesa and Davis, 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_15|23705068|2015|abstract|0:0|show that the lipid acts through a signaling pathway involving an enzyme complex called TORC1 and that the effect of the lipid can be blocked by another protein complex called NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_106|23705068|19337|Results|0:0|Taken together, our biochemical and genetic data indicate that ku540 bypasses the requirement of mmBCFAs and d17iso-GlcCer in development and does so by modifying a regulatory function downstream of d17iso-GlcCer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_127|23705068|24749|Results|0:0|Intact TORC1 function is necessary for mmBCFA-mediated growth regulation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_199|23705068|41772|Discussion|0:0|Third, the TOR pathway is down-regulated by inhibiting the abnormally high GlcCer biosynthesis in polycystic kidney disease in mouse models (Natoli et al., 2010), suggesting a possible conserved link between GlcCer and TOR activities.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_200|23705068|43359|Discussion|0:0|It is currently unknown whether an iso-branched LCB is also required for the potential role of GlcCer in mammals, given that most LCBs in mammals are straight-chain LCBs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_20|23705068|2856|abstract|0:0|thus reveals a novel regulatory function of a specific fatty acid and sphingolipid variant that is used by C. elegans to coordinate its growth and development with its metabolic status or the availability of nutrients.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_209|23705068|44224|Discussion|0:0|If such a mechanism is conserved in all animals, conceptually, d17iso-GlcCer could act as a ligand that binds to a 'receptor' to either repress the NPRL-2/3 complex or activate the TOR complex at the surface of the lysosome.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_217|23705068|45808|Discussion|0:0|Therefore, the only essential biochemical role of d17iso-GlcCer might be to activate TORC1 or repress NPRL-3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_39|23705068|6227|Introduction|0:0|It was not clear whether the essential roles of mmBCFAs and their derived lipids were due to structural requirements for animal development, as was suggested by other studies, or due to regulatory functions specific to cellular signaling processes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_178|23705068|38632|Discussion|0:0|It is conceivable that some of these functions are mediated by this GlcCer/TORC1 signaling pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_438|23705068|69114|Additional files|0:0|P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_26|23705068|3334|Introduction|0:0|While amino acids, energy, and growth factors have been described as nutrient inputs to TOR complexes, roles of lipid molecules as signals to these systems in controlling postembryonic growth and development were not known.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_40|23705068|6227|Introduction|0:0|Testing these hypotheses using model organisms is highly significant because roles of fatty acids and lipids function as nutrient signals for postembryonic development are in general poorly understood.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_43|23705068|7394|Results|0:0|A sphingolipid composed of a mmBCFA-derived long chain base mediates the essential role of mmBCFAs in the initiation of postembryonic growth and development|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_210|23705068|44224|Discussion|0:0|Alternatively, this lipid could be required for lysosome biogenesis or could be an essential constituent of the membrane microdomain that permits the proper localization or activity of TORC1 on the lysosome.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_213|23705068|44224|Discussion|0:0|One possible mechanism is that d17iso-GlcCer acts through the V-ATPase pathway, since the lysosomal V-ATPase has been shown to be stimulated by GlcCer and to play an essential role in TORC1 activation in studies using tissue culture cells (van der Poel et al., 2011; Zoncu et al., 2011; Bar-Peled et al., 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_3|23705068|107|#section_info|0:0|Here, we report that an mmBCFA-derived sphingolipid, d17iso-glucosylceramide, is a critical metabolite in regulating growth and development. Further analysis indicated that this lipid function is mediated by TORC1 and antagonized by the NPRL-2/3 complex in the intestine. Strikingly, the essential lipid function is bypassed by activating TORC1 or inhibiting NPRL-2/3.|#main_body|GO:2000026|regulation of multicellular organismal development|#go_definition|NONE|GOA|nprl-2(177532)|#gene_synonym
0.74	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_46|23705068|7551|Results|0:0|We found that in mmBCFA-deficient elo-5(-) larvae, the amount of mmBCFA-containing sphingolipids were dramatically reduced and thus asked if this mmBCFA function is mediated by a sphingolipid.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_274|23705068|51585|Materials and methods|0:0|The tat-2(-) mutations were also found to partially and temporarily suppress the lethality associated with disrupting the function of the enzyme (SPTL-1) in the first step of sphingolipid biosynthesis, suggesting a potential link between sphingolipids and mmBCFAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_196|23705068|41772|Discussion|0:0|This property is consistent with the role of this complex in repressing TOR-mediated growth regulation that was identified in budding yeast and this study.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_16|23705068|2015|abstract|0:0|TORC1 is well known for its role in sensing amino acids and growth factors, but this is the first time that it has been shown to be involved in detecting lipids.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_193|23705068|41772|Discussion|0:0|The NPRL-3 protein we identified in this pathway is conserved in all eukaryotes, and its negative regulatory role on TOR has been characterized in budding yeast (Neklesa and Davis, 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_15|23705068|2015|abstract|0:0|show that the lipid acts through a signaling pathway involving an enzyme complex called TORC1 and that the effect of the lipid can be blocked by another protein complex called NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_106|23705068|19337|Results|0:0|Taken together, our biochemical and genetic data indicate that ku540 bypasses the requirement of mmBCFAs and d17iso-GlcCer in development and does so by modifying a regulatory function downstream of d17iso-GlcCer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_127|23705068|24749|Results|0:0|Intact TORC1 function is necessary for mmBCFA-mediated growth regulation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_199|23705068|41772|Discussion|0:0|Third, the TOR pathway is down-regulated by inhibiting the abnormally high GlcCer biosynthesis in polycystic kidney disease in mouse models (Natoli et al., 2010), suggesting a possible conserved link between GlcCer and TOR activities.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_200|23705068|43359|Discussion|0:0|It is currently unknown whether an iso-branched LCB is also required for the potential role of GlcCer in mammals, given that most LCBs in mammals are straight-chain LCBs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_20|23705068|2856|abstract|0:0|thus reveals a novel regulatory function of a specific fatty acid and sphingolipid variant that is used by C. elegans to coordinate its growth and development with its metabolic status or the availability of nutrients.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_209|23705068|44224|Discussion|0:0|If such a mechanism is conserved in all animals, conceptually, d17iso-GlcCer could act as a ligand that binds to a 'receptor' to either repress the NPRL-2/3 complex or activate the TOR complex at the surface of the lysosome.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_217|23705068|45808|Discussion|0:0|Therefore, the only essential biochemical role of d17iso-GlcCer might be to activate TORC1 or repress NPRL-3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_39|23705068|6227|Introduction|0:0|It was not clear whether the essential roles of mmBCFAs and their derived lipids were due to structural requirements for animal development, as was suggested by other studies, or due to regulatory functions specific to cellular signaling processes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_178|23705068|38632|Discussion|0:0|It is conceivable that some of these functions are mediated by this GlcCer/TORC1 signaling pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_438|23705068|69114|Additional files|0:0|P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_26|23705068|3334|Introduction|0:0|While amino acids, energy, and growth factors have been described as nutrient inputs to TOR complexes, roles of lipid molecules as signals to these systems in controlling postembryonic growth and development were not known.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_40|23705068|6227|Introduction|0:0|Testing these hypotheses using model organisms is highly significant because roles of fatty acids and lipids function as nutrient signals for postembryonic development are in general poorly understood.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_43|23705068|7394|Results|0:0|A sphingolipid composed of a mmBCFA-derived long chain base mediates the essential role of mmBCFAs in the initiation of postembryonic growth and development|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_210|23705068|44224|Discussion|0:0|Alternatively, this lipid could be required for lysosome biogenesis or could be an essential constituent of the membrane microdomain that permits the proper localization or activity of TORC1 on the lysosome.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_213|23705068|44224|Discussion|0:0|One possible mechanism is that d17iso-GlcCer acts through the V-ATPase pathway, since the lysosomal V-ATPase has been shown to be stimulated by GlcCer and to play an essential role in TORC1 activation in studies using tissue culture cells (van der Poel et al., 2011; Zoncu et al., 2011; Bar-Peled et al., 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_4|23705068|107|#section_info|0:0|Here, we report that an mmBCFA-derived sphingolipid, d17iso-glucosylceramide, is a critical metabolite in regulating growth and development. Further analysis indicated that this lipid function is mediated by TORC1 and antagonized by the NPRL-2/3 complex in the intestine. Strikingly, the essential lipid function is bypassed by activating TORC1 or inhibiting NPRL-2/3.|#main_body|GO:2000026|regulation of multicellular organismal development|#go_definition|NONE|GOA|WBGene00018635(177532)|#gene_synonym
0.74	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_46|23705068|7551|Results|0:0|We found that in mmBCFA-deficient elo-5(-) larvae, the amount of mmBCFA-containing sphingolipids were dramatically reduced and thus asked if this mmBCFA function is mediated by a sphingolipid.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_274|23705068|51585|Materials and methods|0:0|The tat-2(-) mutations were also found to partially and temporarily suppress the lethality associated with disrupting the function of the enzyme (SPTL-1) in the first step of sphingolipid biosynthesis, suggesting a potential link between sphingolipids and mmBCFAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_196|23705068|41772|Discussion|0:0|This property is consistent with the role of this complex in repressing TOR-mediated growth regulation that was identified in budding yeast and this study.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_16|23705068|2015|abstract|0:0|TORC1 is well known for its role in sensing amino acids and growth factors, but this is the first time that it has been shown to be involved in detecting lipids.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_193|23705068|41772|Discussion|0:0|The NPRL-3 protein we identified in this pathway is conserved in all eukaryotes, and its negative regulatory role on TOR has been characterized in budding yeast (Neklesa and Davis, 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_15|23705068|2015|abstract|0:0|show that the lipid acts through a signaling pathway involving an enzyme complex called TORC1 and that the effect of the lipid can be blocked by another protein complex called NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_106|23705068|19337|Results|0:0|Taken together, our biochemical and genetic data indicate that ku540 bypasses the requirement of mmBCFAs and d17iso-GlcCer in development and does so by modifying a regulatory function downstream of d17iso-GlcCer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_127|23705068|24749|Results|0:0|Intact TORC1 function is necessary for mmBCFA-mediated growth regulation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_199|23705068|41772|Discussion|0:0|Third, the TOR pathway is down-regulated by inhibiting the abnormally high GlcCer biosynthesis in polycystic kidney disease in mouse models (Natoli et al., 2010), suggesting a possible conserved link between GlcCer and TOR activities.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_200|23705068|43359|Discussion|0:0|It is currently unknown whether an iso-branched LCB is also required for the potential role of GlcCer in mammals, given that most LCBs in mammals are straight-chain LCBs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_20|23705068|2856|abstract|0:0|thus reveals a novel regulatory function of a specific fatty acid and sphingolipid variant that is used by C. elegans to coordinate its growth and development with its metabolic status or the availability of nutrients.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_209|23705068|44224|Discussion|0:0|If such a mechanism is conserved in all animals, conceptually, d17iso-GlcCer could act as a ligand that binds to a 'receptor' to either repress the NPRL-2/3 complex or activate the TOR complex at the surface of the lysosome.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_217|23705068|45808|Discussion|0:0|Therefore, the only essential biochemical role of d17iso-GlcCer might be to activate TORC1 or repress NPRL-3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_39|23705068|6227|Introduction|0:0|It was not clear whether the essential roles of mmBCFAs and their derived lipids were due to structural requirements for animal development, as was suggested by other studies, or due to regulatory functions specific to cellular signaling processes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_178|23705068|38632|Discussion|0:0|It is conceivable that some of these functions are mediated by this GlcCer/TORC1 signaling pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_438|23705068|69114|Additional files|0:0|P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_26|23705068|3334|Introduction|0:0|While amino acids, energy, and growth factors have been described as nutrient inputs to TOR complexes, roles of lipid molecules as signals to these systems in controlling postembryonic growth and development were not known.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_40|23705068|6227|Introduction|0:0|Testing these hypotheses using model organisms is highly significant because roles of fatty acids and lipids function as nutrient signals for postembryonic development are in general poorly understood.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_43|23705068|7394|Results|0:0|A sphingolipid composed of a mmBCFA-derived long chain base mediates the essential role of mmBCFAs in the initiation of postembryonic growth and development|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_210|23705068|44224|Discussion|0:0|Alternatively, this lipid could be required for lysosome biogenesis or could be an essential constituent of the membrane microdomain that permits the proper localization or activity of TORC1 on the lysosome.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_213|23705068|44224|Discussion|0:0|One possible mechanism is that d17iso-GlcCer acts through the V-ATPase pathway, since the lysosomal V-ATPase has been shown to be stimulated by GlcCer and to play an essential role in TORC1 activation in studies using tissue culture cells (van der Poel et al., 2011; Zoncu et al., 2011; Bar-Peled et al., 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_5|23705068|107|#section_info|0:0|Here, we report that an mmBCFA-derived sphingolipid, d17iso-glucosylceramide, is a critical metabolite in regulating growth and development. Further analysis indicated that this lipid function is mediated by TORC1 and antagonized by the NPRL-2/3 complex in the intestine. Strikingly, the essential lipid function is bypassed by activating TORC1 or inhibiting NPRL-2/3.|#main_body|GO:0040015|negative regulation of multicellular organism growth|#go_definition|NONE|GOA|nprl-3(185331)|#gene_synonym
0.74	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_46|23705068|7551|Results|0:0|We found that in mmBCFA-deficient elo-5(-) larvae, the amount of mmBCFA-containing sphingolipids were dramatically reduced and thus asked if this mmBCFA function is mediated by a sphingolipid.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_274|23705068|51585|Materials and methods|0:0|The tat-2(-) mutations were also found to partially and temporarily suppress the lethality associated with disrupting the function of the enzyme (SPTL-1) in the first step of sphingolipid biosynthesis, suggesting a potential link between sphingolipids and mmBCFAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_196|23705068|41772|Discussion|0:0|This property is consistent with the role of this complex in repressing TOR-mediated growth regulation that was identified in budding yeast and this study.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_16|23705068|2015|abstract|0:0|TORC1 is well known for its role in sensing amino acids and growth factors, but this is the first time that it has been shown to be involved in detecting lipids.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_193|23705068|41772|Discussion|0:0|The NPRL-3 protein we identified in this pathway is conserved in all eukaryotes, and its negative regulatory role on TOR has been characterized in budding yeast (Neklesa and Davis, 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_15|23705068|2015|abstract|0:0|show that the lipid acts through a signaling pathway involving an enzyme complex called TORC1 and that the effect of the lipid can be blocked by another protein complex called NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_106|23705068|19337|Results|0:0|Taken together, our biochemical and genetic data indicate that ku540 bypasses the requirement of mmBCFAs and d17iso-GlcCer in development and does so by modifying a regulatory function downstream of d17iso-GlcCer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_127|23705068|24749|Results|0:0|Intact TORC1 function is necessary for mmBCFA-mediated growth regulation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_199|23705068|41772|Discussion|0:0|Third, the TOR pathway is down-regulated by inhibiting the abnormally high GlcCer biosynthesis in polycystic kidney disease in mouse models (Natoli et al., 2010), suggesting a possible conserved link between GlcCer and TOR activities.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_200|23705068|43359|Discussion|0:0|It is currently unknown whether an iso-branched LCB is also required for the potential role of GlcCer in mammals, given that most LCBs in mammals are straight-chain LCBs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_20|23705068|2856|abstract|0:0|thus reveals a novel regulatory function of a specific fatty acid and sphingolipid variant that is used by C. elegans to coordinate its growth and development with its metabolic status or the availability of nutrients.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_209|23705068|44224|Discussion|0:0|If such a mechanism is conserved in all animals, conceptually, d17iso-GlcCer could act as a ligand that binds to a 'receptor' to either repress the NPRL-2/3 complex or activate the TOR complex at the surface of the lysosome.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_217|23705068|45808|Discussion|0:0|Therefore, the only essential biochemical role of d17iso-GlcCer might be to activate TORC1 or repress NPRL-3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_39|23705068|6227|Introduction|0:0|It was not clear whether the essential roles of mmBCFAs and their derived lipids were due to structural requirements for animal development, as was suggested by other studies, or due to regulatory functions specific to cellular signaling processes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_178|23705068|38632|Discussion|0:0|It is conceivable that some of these functions are mediated by this GlcCer/TORC1 signaling pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_438|23705068|69114|Additional files|0:0|P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_26|23705068|3334|Introduction|0:0|While amino acids, energy, and growth factors have been described as nutrient inputs to TOR complexes, roles of lipid molecules as signals to these systems in controlling postembryonic growth and development were not known.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_40|23705068|6227|Introduction|0:0|Testing these hypotheses using model organisms is highly significant because roles of fatty acids and lipids function as nutrient signals for postembryonic development are in general poorly understood.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_43|23705068|7394|Results|0:0|A sphingolipid composed of a mmBCFA-derived long chain base mediates the essential role of mmBCFAs in the initiation of postembryonic growth and development|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_210|23705068|44224|Discussion|0:0|Alternatively, this lipid could be required for lysosome biogenesis or could be an essential constituent of the membrane microdomain that permits the proper localization or activity of TORC1 on the lysosome.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_213|23705068|44224|Discussion|0:0|One possible mechanism is that d17iso-GlcCer acts through the V-ATPase pathway, since the lysosomal V-ATPase has been shown to be stimulated by GlcCer and to play an essential role in TORC1 activation in studies using tissue culture cells (van der Poel et al., 2011; Zoncu et al., 2011; Bar-Peled et al., 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_6|23705068|107|#section_info|0:0|Here, we report that an mmBCFA-derived sphingolipid, d17iso-glucosylceramide, is a critical metabolite in regulating growth and development. Further analysis indicated that this lipid function is mediated by TORC1 and antagonized by the NPRL-2/3 complex in the intestine. Strikingly, the essential lipid function is bypassed by activating TORC1 or inhibiting NPRL-2/3.|#main_body|GO:0040015|negative regulation of multicellular organism growth|#go_definition|NONE|GOA|WBGene00018072(185331)|#gene_synonym
0.74	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_46|23705068|7551|Results|0:0|We found that in mmBCFA-deficient elo-5(-) larvae, the amount of mmBCFA-containing sphingolipids were dramatically reduced and thus asked if this mmBCFA function is mediated by a sphingolipid.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_274|23705068|51585|Materials and methods|0:0|The tat-2(-) mutations were also found to partially and temporarily suppress the lethality associated with disrupting the function of the enzyme (SPTL-1) in the first step of sphingolipid biosynthesis, suggesting a potential link between sphingolipids and mmBCFAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_196|23705068|41772|Discussion|0:0|This property is consistent with the role of this complex in repressing TOR-mediated growth regulation that was identified in budding yeast and this study.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_16|23705068|2015|abstract|0:0|TORC1 is well known for its role in sensing amino acids and growth factors, but this is the first time that it has been shown to be involved in detecting lipids.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_193|23705068|41772|Discussion|0:0|The NPRL-3 protein we identified in this pathway is conserved in all eukaryotes, and its negative regulatory role on TOR has been characterized in budding yeast (Neklesa and Davis, 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_15|23705068|2015|abstract|0:0|show that the lipid acts through a signaling pathway involving an enzyme complex called TORC1 and that the effect of the lipid can be blocked by another protein complex called NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_106|23705068|19337|Results|0:0|Taken together, our biochemical and genetic data indicate that ku540 bypasses the requirement of mmBCFAs and d17iso-GlcCer in development and does so by modifying a regulatory function downstream of d17iso-GlcCer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_127|23705068|24749|Results|0:0|Intact TORC1 function is necessary for mmBCFA-mediated growth regulation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_199|23705068|41772|Discussion|0:0|Third, the TOR pathway is down-regulated by inhibiting the abnormally high GlcCer biosynthesis in polycystic kidney disease in mouse models (Natoli et al., 2010), suggesting a possible conserved link between GlcCer and TOR activities.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_200|23705068|43359|Discussion|0:0|It is currently unknown whether an iso-branched LCB is also required for the potential role of GlcCer in mammals, given that most LCBs in mammals are straight-chain LCBs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_20|23705068|2856|abstract|0:0|thus reveals a novel regulatory function of a specific fatty acid and sphingolipid variant that is used by C. elegans to coordinate its growth and development with its metabolic status or the availability of nutrients.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_209|23705068|44224|Discussion|0:0|If such a mechanism is conserved in all animals, conceptually, d17iso-GlcCer could act as a ligand that binds to a 'receptor' to either repress the NPRL-2/3 complex or activate the TOR complex at the surface of the lysosome.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_217|23705068|45808|Discussion|0:0|Therefore, the only essential biochemical role of d17iso-GlcCer might be to activate TORC1 or repress NPRL-3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_39|23705068|6227|Introduction|0:0|It was not clear whether the essential roles of mmBCFAs and their derived lipids were due to structural requirements for animal development, as was suggested by other studies, or due to regulatory functions specific to cellular signaling processes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_178|23705068|38632|Discussion|0:0|It is conceivable that some of these functions are mediated by this GlcCer/TORC1 signaling pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_438|23705068|69114|Additional files|0:0|P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_26|23705068|3334|Introduction|0:0|While amino acids, energy, and growth factors have been described as nutrient inputs to TOR complexes, roles of lipid molecules as signals to these systems in controlling postembryonic growth and development were not known.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_40|23705068|6227|Introduction|0:0|Testing these hypotheses using model organisms is highly significant because roles of fatty acids and lipids function as nutrient signals for postembryonic development are in general poorly understood.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_43|23705068|7394|Results|0:0|A sphingolipid composed of a mmBCFA-derived long chain base mediates the essential role of mmBCFAs in the initiation of postembryonic growth and development|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_210|23705068|44224|Discussion|0:0|Alternatively, this lipid could be required for lysosome biogenesis or could be an essential constituent of the membrane microdomain that permits the proper localization or activity of TORC1 on the lysosome.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_213|23705068|44224|Discussion|0:0|One possible mechanism is that d17iso-GlcCer acts through the V-ATPase pathway, since the lysosomal V-ATPase has been shown to be stimulated by GlcCer and to play an essential role in TORC1 activation in studies using tissue culture cells (van der Poel et al., 2011; Zoncu et al., 2011; Bar-Peled et al., 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_7|23705068|107|#section_info|0:0|Here, we report that an mmBCFA-derived sphingolipid, d17iso-glucosylceramide, is a critical metabolite in regulating growth and development. Further analysis indicated that this lipid function is mediated by TORC1 and antagonized by the NPRL-2/3 complex in the intestine. Strikingly, the essential lipid function is bypassed by activating TORC1 or inhibiting NPRL-2/3.|#main_body|GO:2000026|regulation of multicellular organismal development|#go_definition|NONE|GOA|nprl-3(185331)|#gene_synonym
0.74	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_46|23705068|7551|Results|0:0|We found that in mmBCFA-deficient elo-5(-) larvae, the amount of mmBCFA-containing sphingolipids were dramatically reduced and thus asked if this mmBCFA function is mediated by a sphingolipid.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_274|23705068|51585|Materials and methods|0:0|The tat-2(-) mutations were also found to partially and temporarily suppress the lethality associated with disrupting the function of the enzyme (SPTL-1) in the first step of sphingolipid biosynthesis, suggesting a potential link between sphingolipids and mmBCFAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_196|23705068|41772|Discussion|0:0|This property is consistent with the role of this complex in repressing TOR-mediated growth regulation that was identified in budding yeast and this study.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_16|23705068|2015|abstract|0:0|TORC1 is well known for its role in sensing amino acids and growth factors, but this is the first time that it has been shown to be involved in detecting lipids.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_193|23705068|41772|Discussion|0:0|The NPRL-3 protein we identified in this pathway is conserved in all eukaryotes, and its negative regulatory role on TOR has been characterized in budding yeast (Neklesa and Davis, 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_15|23705068|2015|abstract|0:0|show that the lipid acts through a signaling pathway involving an enzyme complex called TORC1 and that the effect of the lipid can be blocked by another protein complex called NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_106|23705068|19337|Results|0:0|Taken together, our biochemical and genetic data indicate that ku540 bypasses the requirement of mmBCFAs and d17iso-GlcCer in development and does so by modifying a regulatory function downstream of d17iso-GlcCer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_127|23705068|24749|Results|0:0|Intact TORC1 function is necessary for mmBCFA-mediated growth regulation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_199|23705068|41772|Discussion|0:0|Third, the TOR pathway is down-regulated by inhibiting the abnormally high GlcCer biosynthesis in polycystic kidney disease in mouse models (Natoli et al., 2010), suggesting a possible conserved link between GlcCer and TOR activities.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_200|23705068|43359|Discussion|0:0|It is currently unknown whether an iso-branched LCB is also required for the potential role of GlcCer in mammals, given that most LCBs in mammals are straight-chain LCBs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_20|23705068|2856|abstract|0:0|thus reveals a novel regulatory function of a specific fatty acid and sphingolipid variant that is used by C. elegans to coordinate its growth and development with its metabolic status or the availability of nutrients.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_209|23705068|44224|Discussion|0:0|If such a mechanism is conserved in all animals, conceptually, d17iso-GlcCer could act as a ligand that binds to a 'receptor' to either repress the NPRL-2/3 complex or activate the TOR complex at the surface of the lysosome.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_217|23705068|45808|Discussion|0:0|Therefore, the only essential biochemical role of d17iso-GlcCer might be to activate TORC1 or repress NPRL-3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_39|23705068|6227|Introduction|0:0|It was not clear whether the essential roles of mmBCFAs and their derived lipids were due to structural requirements for animal development, as was suggested by other studies, or due to regulatory functions specific to cellular signaling processes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_178|23705068|38632|Discussion|0:0|It is conceivable that some of these functions are mediated by this GlcCer/TORC1 signaling pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_438|23705068|69114|Additional files|0:0|P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_26|23705068|3334|Introduction|0:0|While amino acids, energy, and growth factors have been described as nutrient inputs to TOR complexes, roles of lipid molecules as signals to these systems in controlling postembryonic growth and development were not known.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_40|23705068|6227|Introduction|0:0|Testing these hypotheses using model organisms is highly significant because roles of fatty acids and lipids function as nutrient signals for postembryonic development are in general poorly understood.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_43|23705068|7394|Results|0:0|A sphingolipid composed of a mmBCFA-derived long chain base mediates the essential role of mmBCFAs in the initiation of postembryonic growth and development|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_210|23705068|44224|Discussion|0:0|Alternatively, this lipid could be required for lysosome biogenesis or could be an essential constituent of the membrane microdomain that permits the proper localization or activity of TORC1 on the lysosome.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_213|23705068|44224|Discussion|0:0|One possible mechanism is that d17iso-GlcCer acts through the V-ATPase pathway, since the lysosomal V-ATPase has been shown to be stimulated by GlcCer and to play an essential role in TORC1 activation in studies using tissue culture cells (van der Poel et al., 2011; Zoncu et al., 2011; Bar-Peled et al., 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_8|23705068|107|#section_info|0:0|Here, we report that an mmBCFA-derived sphingolipid, d17iso-glucosylceramide, is a critical metabolite in regulating growth and development. Further analysis indicated that this lipid function is mediated by TORC1 and antagonized by the NPRL-2/3 complex in the intestine. Strikingly, the essential lipid function is bypassed by activating TORC1 or inhibiting NPRL-2/3.|#main_body|GO:2000026|regulation of multicellular organismal development|#go_definition|NONE|GOA|WBGene00018072(185331)|#gene_synonym
0.74	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_46|23705068|7551|Results|0:0|We found that in mmBCFA-deficient elo-5(-) larvae, the amount of mmBCFA-containing sphingolipids were dramatically reduced and thus asked if this mmBCFA function is mediated by a sphingolipid.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_274|23705068|51585|Materials and methods|0:0|The tat-2(-) mutations were also found to partially and temporarily suppress the lethality associated with disrupting the function of the enzyme (SPTL-1) in the first step of sphingolipid biosynthesis, suggesting a potential link between sphingolipids and mmBCFAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_196|23705068|41772|Discussion|0:0|This property is consistent with the role of this complex in repressing TOR-mediated growth regulation that was identified in budding yeast and this study.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_16|23705068|2015|abstract|0:0|TORC1 is well known for its role in sensing amino acids and growth factors, but this is the first time that it has been shown to be involved in detecting lipids.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_193|23705068|41772|Discussion|0:0|The NPRL-3 protein we identified in this pathway is conserved in all eukaryotes, and its negative regulatory role on TOR has been characterized in budding yeast (Neklesa and Davis, 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_15|23705068|2015|abstract|0:0|show that the lipid acts through a signaling pathway involving an enzyme complex called TORC1 and that the effect of the lipid can be blocked by another protein complex called NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_106|23705068|19337|Results|0:0|Taken together, our biochemical and genetic data indicate that ku540 bypasses the requirement of mmBCFAs and d17iso-GlcCer in development and does so by modifying a regulatory function downstream of d17iso-GlcCer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_127|23705068|24749|Results|0:0|Intact TORC1 function is necessary for mmBCFA-mediated growth regulation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_199|23705068|41772|Discussion|0:0|Third, the TOR pathway is down-regulated by inhibiting the abnormally high GlcCer biosynthesis in polycystic kidney disease in mouse models (Natoli et al., 2010), suggesting a possible conserved link between GlcCer and TOR activities.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_200|23705068|43359|Discussion|0:0|It is currently unknown whether an iso-branched LCB is also required for the potential role of GlcCer in mammals, given that most LCBs in mammals are straight-chain LCBs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_20|23705068|2856|abstract|0:0|thus reveals a novel regulatory function of a specific fatty acid and sphingolipid variant that is used by C. elegans to coordinate its growth and development with its metabolic status or the availability of nutrients.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_209|23705068|44224|Discussion|0:0|If such a mechanism is conserved in all animals, conceptually, d17iso-GlcCer could act as a ligand that binds to a 'receptor' to either repress the NPRL-2/3 complex or activate the TOR complex at the surface of the lysosome.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_217|23705068|45808|Discussion|0:0|Therefore, the only essential biochemical role of d17iso-GlcCer might be to activate TORC1 or repress NPRL-3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_39|23705068|6227|Introduction|0:0|It was not clear whether the essential roles of mmBCFAs and their derived lipids were due to structural requirements for animal development, as was suggested by other studies, or due to regulatory functions specific to cellular signaling processes.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_178|23705068|38632|Discussion|0:0|It is conceivable that some of these functions are mediated by this GlcCer/TORC1 signaling pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_438|23705068|69114|Additional files|0:0|P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_26|23705068|3334|Introduction|0:0|While amino acids, energy, and growth factors have been described as nutrient inputs to TOR complexes, roles of lipid molecules as signals to these systems in controlling postembryonic growth and development were not known.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_40|23705068|6227|Introduction|0:0|Testing these hypotheses using model organisms is highly significant because roles of fatty acids and lipids function as nutrient signals for postembryonic development are in general poorly understood.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_43|23705068|7394|Results|0:0|A sphingolipid composed of a mmBCFA-derived long chain base mediates the essential role of mmBCFAs in the initiation of postembryonic growth and development|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_210|23705068|44224|Discussion|0:0|Alternatively, this lipid could be required for lysosome biogenesis or could be an essential constituent of the membrane microdomain that permits the proper localization or activity of TORC1 on the lysosome.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_213|23705068|44224|Discussion|0:0|One possible mechanism is that d17iso-GlcCer acts through the V-ATPase pathway, since the lysosomal V-ATPase has been shown to be stimulated by GlcCer and to play an essential role in TORC1 activation in studies using tissue culture cells (van der Poel et al., 2011; Zoncu et al., 2011; Bar-Peled et al., 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_9|23705068|6980|#section_info|0:0|In this study, we discovered that (1) an mmBCFA-derived glucosylceramide (d17iso-GlcCer) mediates the function of mmBCFAs in promoting postembryonic growth and development and (2) d17iso-GlcCer acts through a signaling system that includes the NPRL-2/NPRL-3 protein complex (negative factor) and TORC1 (positive factor) to promote postembryonic development.|#main_body|GO:0048581|negative regulation of post-embryonic development|#go_definition|NONE|GOA|nprl-2(177532)|#gene_synonym
0.64	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_169|23705068|35699|Results|0:0|The mmBCFA/d17iso-GlcCer/TORC1 pathway acts in the intestine to promote postembryonic development|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_10|23705068|6980|#section_info|0:0|In this study, we discovered that (1) an mmBCFA-derived glucosylceramide (d17iso-GlcCer) mediates the function of mmBCFAs in promoting postembryonic growth and development and (2) d17iso-GlcCer acts through a signaling system that includes the NPRL-2/NPRL-3 protein complex (negative factor) and TORC1 (positive factor) to promote postembryonic development.|#main_body|GO:0048581|negative regulation of post-embryonic development|#go_definition|NONE|GOA|WBGene00018635(177532)|#gene_synonym
0.64	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_169|23705068|35699|Results|0:0|The mmBCFA/d17iso-GlcCer/TORC1 pathway acts in the intestine to promote postembryonic development|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_11|23705068|6980|#section_info|0:0|In this study, we discovered that (1) an mmBCFA-derived glucosylceramide (d17iso-GlcCer) mediates the function of mmBCFAs in promoting postembryonic growth and development and (2) d17iso-GlcCer acts through a signaling system that includes the NPRL-2/NPRL-3 protein complex (negative factor) and TORC1 (positive factor) to promote postembryonic development.|#main_body|GO:0048581|negative regulation of post-embryonic development|#go_definition|NONE|GOA|nplr-3(185331)|#gene_synonym
0.64	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_169|23705068|35699|Results|0:0|The mmBCFA/d17iso-GlcCer/TORC1 pathway acts in the intestine to promote postembryonic development|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_12|23705068|6980|#section_info|0:0|In this study, we discovered that (1) an mmBCFA-derived glucosylceramide (d17iso-GlcCer) mediates the function of mmBCFAs in promoting postembryonic growth and development and (2) d17iso-GlcCer acts through a signaling system that includes the NPRL-2/NPRL-3 protein complex (negative factor) and TORC1 (positive factor) to promote postembryonic development.|#main_body|GO:0048581|negative regulation of post-embryonic development|#go_definition|NONE|GOA|WBGene00018072(185331)|#gene_synonym
0.64	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_169|23705068|35699|Results|0:0|The mmBCFA/d17iso-GlcCer/TORC1 pathway acts in the intestine to promote postembryonic development|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_13|23705068|7991|#section_info|0:0|Iso-branched d17iso-sphinganine rescues elo-5(-) L1 arrest.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
23705068_14|23705068|7991|#section_info|0:0|Iso-branched d17iso-sphinganine rescues elo-5(-) L1 arrest.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
23705068_15|23705068|9992|#section_info|0:0|We then examined if dietary supplementation with either of these two types of sphingolipids could substitute for mmBCFAs to rescue elo-5(-) animals from L1 arrest.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
23705068_16|23705068|9992|#section_info|0:0|We then examined if dietary supplementation with either of these two types of sphingolipids could substitute for mmBCFAs to rescue elo-5(-) animals from L1 arrest.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
23705068_17|23705068|9992|#section_info|0:0|This purified d17iso-SPA fraction, but not a chemically synthesized c17iso-sphingolipid with a straight-chain d18:1-LCB or a straight-chain LCB d16-SPA, was found to be sufficient to overcome elo-5(-) L1 arrest (Figure 1B,C; Supplementary file 1).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
23705068_18|23705068|9992|#section_info|0:0|This purified d17iso-SPA fraction, but not a chemically synthesized c17iso-sphingolipid with a straight-chain d18:1-LCB or a straight-chain LCB d16-SPA, was found to be sufficient to overcome elo-5(-) L1 arrest (Figure 1B,C; Supplementary file 1).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
23705068_19|23705068|10859|#section_info|0:0|First, we fed elo-5(-) larvae with various quantities of C15ISO, C17ISO, or d17iso-SPA. We observed that d17iso-SPA suppressed the L1 arrest at a much lower concentration than C15ISO or C17ISO (Figure 1D). Second, we observed that the low concentrations of d17iso-SPA suppressed the L1 arrest without restoring mmBCFA levels (Figure 1E). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.64	23705068_271|23705068|51585|Materials and methods|0:0|In our previously published screen (Seamen et al., 2009), we isolated three mutations in tat-2 that can suppress elo-5(-)-induced L1 arrest in the presence of C13ISO, or temporarily suppress the L1 arrest for one generation without C13ISO supplement.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_20|23705068|10859|#section_info|0:0|First, we fed elo-5(-) larvae with various quantities of C15ISO, C17ISO, or d17iso-SPA. We observed that d17iso-SPA suppressed the L1 arrest at a much lower concentration than C15ISO or C17ISO (Figure 1D). Second, we observed that the low concentrations of d17iso-SPA suppressed the L1 arrest without restoring mmBCFA levels (Figure 1E). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.64	23705068_271|23705068|51585|Materials and methods|0:0|In our previously published screen (Seamen et al., 2009), we isolated three mutations in tat-2 that can suppress elo-5(-)-induced L1 arrest in the presence of C13ISO, or temporarily suppress the L1 arrest for one generation without C13ISO supplement.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_21|23705068|10859|#section_info|0:0|Finally, we found that supplementation with d17iso-SPA, but not mmBCFAs, also suppressed the L1 arrest phenotype caused by feeding RNAi of sptl-1, a gene encoding a serine palmitoyltransferase homolog in C. elegans required for d17iso-SPA biosynthesis (Figure 1A,B; Seamen et al., 2009).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|sptl-1(173389)|#gene_synonym
0.68	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_438|23705068|69114|Additional files|0:0|P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_271|23705068|51585|Materials and methods|0:0|In our previously published screen (Seamen et al., 2009), we isolated three mutations in tat-2 that can suppress elo-5(-)-induced L1 arrest in the presence of C13ISO, or temporarily suppress the L1 arrest for one generation without C13ISO supplement.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_155|23705068|31057|Results|0:0|asna-1 encodes a protein required for proper DAF-7/TGF-beta function and an asna-1(-) mutation causes L1 arrest (Kao et al., 2007).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_166|23705068|33611|Results|0:0|Both Rap-1 and Raptor proteins are highly conserved in C. elegans (encoded by rap-1 and daf-15; Long et al., 2002; Pellis-van Berkel et al., 2005).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_198|23705068|41772|Discussion|0:0|The finding that mouse mutants with blocked GlcCer biosynthesis die as early embryos suggests the essential role of these lipids in growth and development (Yamashita et al., 1999).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_274|23705068|51585|Materials and methods|0:0|The tat-2(-) mutations were also found to partially and temporarily suppress the lethality associated with disrupting the function of the enzyme (SPTL-1) in the first step of sphingolipid biosynthesis, suggesting a potential link between sphingolipids and mmBCFAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_22|23705068|10859|#section_info|0:0|Finally, we found that supplementation with d17iso-SPA, but not mmBCFAs, also suppressed the L1 arrest phenotype caused by feeding RNAi of sptl-1, a gene encoding a serine palmitoyltransferase homolog in C. elegans required for d17iso-SPA biosynthesis (Figure 1A,B; Seamen et al., 2009).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00016020(173389)|#gene_synonym
0.68	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_438|23705068|69114|Additional files|0:0|P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_271|23705068|51585|Materials and methods|0:0|In our previously published screen (Seamen et al., 2009), we isolated three mutations in tat-2 that can suppress elo-5(-)-induced L1 arrest in the presence of C13ISO, or temporarily suppress the L1 arrest for one generation without C13ISO supplement.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_155|23705068|31057|Results|0:0|asna-1 encodes a protein required for proper DAF-7/TGF-beta function and an asna-1(-) mutation causes L1 arrest (Kao et al., 2007).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_166|23705068|33611|Results|0:0|Both Rap-1 and Raptor proteins are highly conserved in C. elegans (encoded by rap-1 and daf-15; Long et al., 2002; Pellis-van Berkel et al., 2005).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_198|23705068|41772|Discussion|0:0|The finding that mouse mutants with blocked GlcCer biosynthesis die as early embryos suggests the essential role of these lipids in growth and development (Yamashita et al., 1999).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_274|23705068|51585|Materials and methods|0:0|The tat-2(-) mutations were also found to partially and temporarily suppress the lethality associated with disrupting the function of the enzyme (SPTL-1) in the first step of sphingolipid biosynthesis, suggesting a potential link between sphingolipids and mmBCFAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_23|23705068|11786|#section_info|0:0|Both fath-1(RNAi)-treated animals (Figure 1B; Supplementary file 1) and the cgt-1(-);cgt-3(-) double mutant (Marza et al., 2009) cause larval arrest. |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|fath-1(172882)|#gene_synonym
0.62	23705068_307|23705068|56480|Materials and methods|0:0|Furthermore, results from those references and our experiments have shown RNAi feeding of these genes did not reproduce the strong larval lethal phenotype (Hansen et al., 2007; Syntichaki et al., 2007; Lemire et al., 2009; Ching et al., 2010; Polley and Fay, 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_211|23705068|44224|Discussion|0:0|By examining lysosomal markers LMP-1::GFP (Artal-Sanz et al., 2006; O'Rourke et al., 2009; Rabbitts et al., 2008), GLO-1::GFP (Schroeder et al., 2007; Zhang et al., 2010), and Neutral red (Long et al., 2002), we did not observe obvious defects in lysosome formation in elo-5(-) mutants (Figure 4:figure supplements 4 and 5).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_24|23705068|11786|#section_info|0:0|Both fath-1(RNAi)-treated animals (Figure 1B; Supplementary file 1) and the cgt-1(-);cgt-3(-) double mutant (Marza et al., 2009) cause larval arrest. |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00007707(172882)|#gene_synonym
0.62	23705068_307|23705068|56480|Materials and methods|0:0|Furthermore, results from those references and our experiments have shown RNAi feeding of these genes did not reproduce the strong larval lethal phenotype (Hansen et al., 2007; Syntichaki et al., 2007; Lemire et al., 2009; Ching et al., 2010; Polley and Fay, 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_211|23705068|44224|Discussion|0:0|By examining lysosomal markers LMP-1::GFP (Artal-Sanz et al., 2006; O'Rourke et al., 2009; Rabbitts et al., 2008), GLO-1::GFP (Schroeder et al., 2007; Zhang et al., 2010), and Neutral red (Long et al., 2002), we did not observe obvious defects in lysosome formation in elo-5(-) mutants (Figure 4:figure supplements 4 and 5).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_25|23705068|11786|#section_info|0:0|Both fath-1(RNAi)-treated animals (Figure 1B; Supplementary file 1) and the cgt-1(-);cgt-3(-) double mutant (Marza et al., 2009) cause larval arrest. |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|cgt-2(181790)|#gene_synonym
0.62	23705068_307|23705068|56480|Materials and methods|0:0|Furthermore, results from those references and our experiments have shown RNAi feeding of these genes did not reproduce the strong larval lethal phenotype (Hansen et al., 2007; Syntichaki et al., 2007; Lemire et al., 2009; Ching et al., 2010; Polley and Fay, 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_211|23705068|44224|Discussion|0:0|By examining lysosomal markers LMP-1::GFP (Artal-Sanz et al., 2006; O'Rourke et al., 2009; Rabbitts et al., 2008), GLO-1::GFP (Schroeder et al., 2007; Zhang et al., 2010), and Neutral red (Long et al., 2002), we did not observe obvious defects in lysosome formation in elo-5(-) mutants (Figure 4:figure supplements 4 and 5).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_26|23705068|11786|#section_info|0:0|Both fath-1(RNAi)-treated animals (Figure 1B; Supplementary file 1) and the cgt-1(-);cgt-3(-) double mutant (Marza et al., 2009) cause larval arrest. |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00017625(181790)|#gene_synonym
0.62	23705068_307|23705068|56480|Materials and methods|0:0|Furthermore, results from those references and our experiments have shown RNAi feeding of these genes did not reproduce the strong larval lethal phenotype (Hansen et al., 2007; Syntichaki et al., 2007; Lemire et al., 2009; Ching et al., 2010; Polley and Fay, 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_211|23705068|44224|Discussion|0:0|By examining lysosomal markers LMP-1::GFP (Artal-Sanz et al., 2006; O'Rourke et al., 2009; Rabbitts et al., 2008), GLO-1::GFP (Schroeder et al., 2007; Zhang et al., 2010), and Neutral red (Long et al., 2002), we did not observe obvious defects in lysosome formation in elo-5(-) mutants (Figure 4:figure supplements 4 and 5).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_27|23705068|11786|#section_info|0:0|Both fath-1(RNAi)-treated animals (Figure 1B; Supplementary file 1) and the cgt-1(-);cgt-3(-) double mutant (Marza et al., 2009) cause larval arrest. |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|cgt-1(188169)|#gene_synonym
0.62	23705068_307|23705068|56480|Materials and methods|0:0|Furthermore, results from those references and our experiments have shown RNAi feeding of these genes did not reproduce the strong larval lethal phenotype (Hansen et al., 2007; Syntichaki et al., 2007; Lemire et al., 2009; Ching et al., 2010; Polley and Fay, 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_211|23705068|44224|Discussion|0:0|By examining lysosomal markers LMP-1::GFP (Artal-Sanz et al., 2006; O'Rourke et al., 2009; Rabbitts et al., 2008), GLO-1::GFP (Schroeder et al., 2007; Zhang et al., 2010), and Neutral red (Long et al., 2002), we did not observe obvious defects in lysosome formation in elo-5(-) mutants (Figure 4:figure supplements 4 and 5).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_28|23705068|11786|#section_info|0:0|Both fath-1(RNAi)-treated animals (Figure 1B; Supplementary file 1) and the cgt-1(-);cgt-3(-) double mutant (Marza et al., 2009) cause larval arrest. |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00011517(188169)|#gene_synonym
0.62	23705068_307|23705068|56480|Materials and methods|0:0|Furthermore, results from those references and our experiments have shown RNAi feeding of these genes did not reproduce the strong larval lethal phenotype (Hansen et al., 2007; Syntichaki et al., 2007; Lemire et al., 2009; Ching et al., 2010; Polley and Fay, 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_211|23705068|44224|Discussion|0:0|By examining lysosomal markers LMP-1::GFP (Artal-Sanz et al., 2006; O'Rourke et al., 2009; Rabbitts et al., 2008), GLO-1::GFP (Schroeder et al., 2007; Zhang et al., 2010), and Neutral red (Long et al., 2002), we did not observe obvious defects in lysosome formation in elo-5(-) mutants (Figure 4:figure supplements 4 and 5).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_29|23705068|13109|#section_info|0:0|Mutation ku540 permits mmBCFA-depleted C. elegans to bypass L1 arrest and propagate continuously|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|NONE|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_30|23705068|13109|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|NONE|GOA|WBGene00018072(185331)|#gene_synonym
##EndOfRet##
23705068_31|23705068|13206|#section_info|0:0|ku540 mutant suppresses L1 arrest of mmBCFA and sphingolipid biosynthetic mutants without restoring the levels of mmBCFAs.|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|NONE|GOA|nprl-3(185331)|#gene_synonym
0.64	23705068_274|23705068|51585|Materials and methods|0:0|The tat-2(-) mutations were also found to partially and temporarily suppress the lethality associated with disrupting the function of the enzyme (SPTL-1) in the first step of sphingolipid biosynthesis, suggesting a potential link between sphingolipids and mmBCFAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_32|23705068|13206|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|NONE|GOA|WBGene00018072(185331)|#gene_synonym
##EndOfRet##
23705068_33|23705068|13329|#section_info|0:0|) animals arrested at L1 and elo-5(-);ku540 animals reached adulthood.|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
23705068_34|23705068|13329|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
23705068_35|23705068|13329|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#fig_caption|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_36|23705068|13329|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#fig_caption|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
##EndOfRet##
23705068_37|23705068|13329|#section_info|0:0|(H) The addition of ku540 dramatically suppressed the L1 arrest phenotype of cgt-1(-);cgt-3(RNAi) with and without the C17ISO supplement. The inclusion of elo-5(-) was due to its close linkage with ku540. When C17ISO was added to remove the negative effect of elo-5( cgt-1(-);cgt-3(RNAi) animals reached adulthood. C17ISO itself does not rescue the phenotype. |#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|cgt-2(181790)|#gene_synonym
0.64	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_271|23705068|51585|Materials and methods|0:0|In our previously published screen (Seamen et al., 2009), we isolated three mutations in tat-2 that can suppress elo-5(-)-induced L1 arrest in the presence of C13ISO, or temporarily suppress the L1 arrest for one generation without C13ISO supplement.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_38|23705068|13329|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00017625(181790)|#gene_synonym
##EndOfRet##
23705068_39|23705068|13329|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|cgt-1(188169)|#gene_synonym
##EndOfRet##
23705068_40|23705068|13329|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00011517(188169)|#gene_synonym
##EndOfRet##
23705068_41|23705068|13329|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#fig_caption|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_42|23705068|13329|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#fig_caption|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
##EndOfRet##
23705068_43|23705068|13329|#section_info|0:0|ku540 suppressed the L1 arrest phenotype the cgt-1(-);cgt-3 (-) double mutants (83.4%, n = 126). |#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|cgt-2(181790)|#gene_synonym
0.63	23705068_271|23705068|51585|Materials and methods|0:0|In our previously published screen (Seamen et al., 2009), we isolated three mutations in tat-2 that can suppress elo-5(-)-induced L1 arrest in the presence of C13ISO, or temporarily suppress the L1 arrest for one generation without C13ISO supplement.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_44|23705068|13329|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00017625(181790)|#gene_synonym
##EndOfRet##
23705068_45|23705068|13329|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|cgt-1(188169)|#gene_synonym
##EndOfRet##
23705068_46|23705068|13329|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00011517(188169)|#gene_synonym
##EndOfRet##
23705068_47|23705068|13329|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#fig_caption|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_48|23705068|13329|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#fig_caption|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
##EndOfRet##
23705068_49|23705068|17108|#section_info|0:0|Microscopic images showing that nprl-3(ku540) suppresses the L1 arrest phenotype of fath-1 (injection RNAi) with or without C17ISO supplementation.|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|fath-1(172882)|#gene_synonym
##EndOfRet##
23705068_50|23705068|17108|#section_info|0:0|Microscopic images showing that nprl-3(ku540) suppresses the L1 arrest phenotype of fath-1 (injection RNAi) with or without C17ISO supplementation.|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00007707(172882)|#gene_synonym
##EndOfRet##
23705068_51|23705068|17108|#section_info|0:0|Microscopic images showing that nprl-3(ku540) suppresses the L1 arrest phenotype of fath-1 (injection RNAi) with or without C17ISO supplementation.|#fig_caption|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_52|23705068|17108|#section_info|0:0|Microscopic images showing that nprl-3(ku540) suppresses the L1 arrest phenotype of fath-1 (injection RNAi) with or without C17ISO supplementation.|#fig_caption|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
##EndOfRet##
23705068_53|23705068|17303|#section_info|0:0|To test this possibility and identify the mechanism, we performed a genetic screen, modified from a previous screen (Seamen et al., 2009), for mutations that could suppress the L1 arrest of elo-5(-) mutants (Figure 2A).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.72	23705068_271|23705068|51585|Materials and methods|0:0|In our previously published screen (Seamen et al., 2009), we isolated three mutations in tat-2 that can suppress elo-5(-)-induced L1 arrest in the presence of C13ISO, or temporarily suppress the L1 arrest for one generation without C13ISO supplement.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	23705068_265|23705068|50565|Materials and methods|0:0|We performed a screen that was significantly different from our previously published screen that resulted in isolation of three tat-2(-) alleles that suppress elo-5(gk208) (Seamen et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_270|23705068|50565|Materials and methods|0:0|Among these four, and several suppressor mutations isolated in a previous screen (Seamen et al., 2009), only ku540 permits elo-5(-) animals to grow indefinitely without any mmBCFA supplementation and without recovering the production of mmBCFAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_54|23705068|17303|#section_info|0:0|To test this possibility and identify the mechanism, we performed a genetic screen, modified from a previous screen (Seamen et al., 2009), for mutations that could suppress the L1 arrest of elo-5(-) mutants (Figure 2A).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.72	23705068_271|23705068|51585|Materials and methods|0:0|In our previously published screen (Seamen et al., 2009), we isolated three mutations in tat-2 that can suppress elo-5(-)-induced L1 arrest in the presence of C13ISO, or temporarily suppress the L1 arrest for one generation without C13ISO supplement.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	23705068_265|23705068|50565|Materials and methods|0:0|We performed a screen that was significantly different from our previously published screen that resulted in isolation of three tat-2(-) alleles that suppress elo-5(gk208) (Seamen et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_270|23705068|50565|Materials and methods|0:0|Among these four, and several suppressor mutations isolated in a previous screen (Seamen et al., 2009), only ku540 permits elo-5(-) animals to grow indefinitely without any mmBCFA supplementation and without recovering the production of mmBCFAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_55|23705068|17303|#section_info|0:0|Among four suppressors identified in this screen, and the tat-2 mutations from a previous elo-5(-) suppressor screen (Seamen et al., 2009), ku540 was the only mutation that rescued elo-5(-) larvae to adults and permitted growth for more than one generation without mmBCFA supplementation or restoration of mmBCFA synthesis (Figure 2B-E; see 'Materials and methods').|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.76	23705068_270|23705068|50565|Materials and methods|0:0|Among these four, and several suppressor mutations isolated in a previous screen (Seamen et al., 2009), only ku540 permits elo-5(-) animals to grow indefinitely without any mmBCFA supplementation and without recovering the production of mmBCFAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_271|23705068|51585|Materials and methods|0:0|In our previously published screen (Seamen et al., 2009), we isolated three mutations in tat-2 that can suppress elo-5(-)-induced L1 arrest in the presence of C13ISO, or temporarily suppress the L1 arrest for one generation without C13ISO supplement.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_265|23705068|50565|Materials and methods|0:0|We performed a screen that was significantly different from our previously published screen that resulted in isolation of three tat-2(-) alleles that suppress elo-5(gk208) (Seamen et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_56|23705068|17303|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
23705068_57|23705068|17303|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_58|23705068|17303|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
##EndOfRet##
23705068_59|23705068|17303|#section_info|0:0|To test this possibility and identify the mechanism, we performed a genetic screen, modified from a previous screen (Seamen et al., 2009), for mutations that could suppress the L1 arrest of elo-5(-) mutants (Figure 2A).|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
0.72	23705068_271|23705068|51585|Materials and methods|0:0|In our previously published screen (Seamen et al., 2009), we isolated three mutations in tat-2 that can suppress elo-5(-)-induced L1 arrest in the presence of C13ISO, or temporarily suppress the L1 arrest for one generation without C13ISO supplement.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	23705068_265|23705068|50565|Materials and methods|0:0|We performed a screen that was significantly different from our previously published screen that resulted in isolation of three tat-2(-) alleles that suppress elo-5(gk208) (Seamen et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_270|23705068|50565|Materials and methods|0:0|Among these four, and several suppressor mutations isolated in a previous screen (Seamen et al., 2009), only ku540 permits elo-5(-) animals to grow indefinitely without any mmBCFA supplementation and without recovering the production of mmBCFAs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_60|23705068|17303|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
##EndOfRet##
23705068_59|23705068|18344|#section_info|0:0|These data indicated that the suppression of L1 arrest by the ku540 mutation is neither due to a change in mmBCFA nor the metabolism of the derived sphingolipids. |#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_61|23705068|19337|#section_info|0:0|As shown above, RNAi of fath-1, or mutating both cgt-1 and cgt-3, caused larval arrest that could not be rescued by feeding with either mmBCFAs or d17iso-SPA (Figure 1A,B).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|fath-1(172882)|#gene_synonym
0.61	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_62|23705068|19337|#section_info|0:0|As shown above, RNAi of fath-1, or mutating both cgt-1 and cgt-3, caused larval arrest that could not be rescued by feeding with either mmBCFAs or d17iso-SPA (Figure 1A,B).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00007707(172882)|#gene_synonym
0.61	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_63|23705068|19337|#section_info|0:0|As shown above, RNAi of fath-1, or mutating both cgt-1 and cgt-3, caused larval arrest that could not be rescued by feeding with either mmBCFAs or d17iso-SPA (Figure 1A,B).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|cgt-2(181790)|#gene_synonym
0.61	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_64|23705068|19337|#section_info|0:0|As shown above, RNAi of fath-1, or mutating both cgt-1 and cgt-3, caused larval arrest that could not be rescued by feeding with either mmBCFAs or d17iso-SPA (Figure 1A,B).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00017625(181790)|#gene_synonym
0.61	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_65|23705068|19337|#section_info|0:0|As shown above, RNAi of fath-1, or mutating both cgt-1 and cgt-3, caused larval arrest that could not be rescued by feeding with either mmBCFAs or d17iso-SPA (Figure 1A,B).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|cgt-1(188169)|#gene_synonym
0.61	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_66|23705068|19337|#section_info|0:0|As shown above, RNAi of fath-1, or mutating both cgt-1 and cgt-3, caused larval arrest that could not be rescued by feeding with either mmBCFAs or d17iso-SPA (Figure 1A,B).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00011517(188169)|#gene_synonym
0.61	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_67|23705068|19337|#section_info|0:0|As shown above, RNAi of fath-1, or mutating both cgt-1 and cgt-3, caused larval arrest that could not be rescued by feeding with either mmBCFAs or d17iso-SPA (Figure 1A,B). We found that the L1 arrest under both conditions, just like the arrest caused by elo-5(|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
0.65	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_68|23705068|19337|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
##EndOfRet##
23705068_69|23705068|19337|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_70|23705068|19337|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
##EndOfRet##
23705068_29|23705068|20313|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|NONE|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_55|23705068|20313|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
23705068_71|23705068|20313|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_59|23705068|20313|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_67|23705068|20313|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_72|23705068|20313|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_31|23705068|20313|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|NONE|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_33|23705068|20313|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
23705068_73|23705068|20313|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_37|23705068|20313|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|cgt-2(181790)|#gene_synonym
##EndOfRet##
23705068_74|23705068|20313|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|cgt-1(188169)|#gene_synonym
##EndOfRet##
23705068_75|23705068|20313|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_43|23705068|20313|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|cgt-2(181790)|#gene_synonym
##EndOfRet##
23705068_76|23705068|20313|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|cgt-1(188169)|#gene_synonym
##EndOfRet##
23705068_77|23705068|20313|#section_info|0:0|ku540 is a loss-of-function mutation of nprl-3 that may function with nprl-2|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_78|23705068|20447|#section_info|0:0|nprl-3 dsRNA injection rescued 61.0% of elo-5(-) (n = 123) and 6.8% of cgt-1(-) cgt-3(-) (n = 71) animals to or beyond L3 stage. |#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
23705068_79|23705068|20447|#section_info|0:0|nprl-3 dsRNA injection rescued 61.0% of elo-5(-) (n = 123) and 6.8% of cgt-1(-) cgt-3(-) (n = 71) animals to or beyond L3 stage. |#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
23705068_80|23705068|20447|#section_info|0:0|nprl-3 dsRNA injection rescued 61.0% of elo-5(-) (n = 123) and 6.8% of cgt-1(-) cgt-3(-) (n = 71) animals to or beyond L3 stage. |#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|cgt-2(181790)|#gene_synonym
##EndOfRet##
23705068_81|23705068|20447|#section_info|0:0|nprl-3 dsRNA injection rescued 61.0% of elo-5(-) (n = 123) and 6.8% of cgt-1(-) cgt-3(-) (n = 71) animals to or beyond L3 stage. |#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00017625(181790)|#gene_synonym
##EndOfRet##
23705068_82|23705068|20447|#section_info|0:0|nprl-3 dsRNA injection rescued 61.0% of elo-5(-) (n = 123) and 6.8% of cgt-1(-) cgt-3(-) (n = 71) animals to or beyond L3 stage. |#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|cgt-1(188169)|#gene_synonym
##EndOfRet##
23705068_83|23705068|20447|#section_info|0:0|nprl-3 dsRNA injection rescued 61.0% of elo-5(-) (n = 123) and 6.8% of cgt-1(-) cgt-3(-) (n = 71) animals to or beyond L3 stage. |#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00011517(188169)|#gene_synonym
##EndOfRet##
23705068_84|23705068|20447|#section_info|0:0|nprl-3 dsRNA injection rescued 61.0% of elo-5(-) (n = 123) and 6.8% of cgt-1(-) cgt-3(-) (n = 71) animals to or beyond L3 stage. |#fig_caption|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_85|23705068|20447|#section_info|0:0|nprl-3 dsRNA injection rescued 61.0% of elo-5(-) (n = 123) and 6.8% of cgt-1(-) cgt-3(-) (n = 71) animals to or beyond L3 stage. |#fig_caption|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
##EndOfRet##
23705068_86|23705068|20447|#section_info|0:0|nprl-3 dsRNA injection rescued 61.0% of elo-5(-) (n = 123) and 6.8% of cgt-1(-) cgt-3(-) (n = 71) animals to or beyond L3 stage. |#fig_caption|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_87|23705068|20447|#section_info|0:0|nprl-3 dsRNA injection rescued 61.0% of elo-5(-) (n = 123) and 6.8% of cgt-1(-) cgt-3(-) (n = 71) animals to or beyond L3 stage. |#fig_caption|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
##EndOfRet##
23705068_88|23705068|20447|#section_info|0:0|nprl-2 dsRNA injection also rescued 42.4% of elo-5(-) animals to or beyond L3 stage (n = 128). |#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
23705068_89|23705068|20447|#section_info|0:0|nprl-2 dsRNA injection also rescued 42.4% of elo-5(-) animals to or beyond L3 stage (n = 128). |#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
23705068_90|23705068|20447|#section_info|0:0|nprl-2 dsRNA injection also rescued 42.4% of elo-5(-) animals to or beyond L3 stage (n = 128). |#fig_caption|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-2(177532)|#gene_synonym
##EndOfRet##
23705068_91|23705068|20447|#section_info|0:0|nprl-2 dsRNA injection also rescued 42.4% of elo-5(-) animals to or beyond L3 stage (n = 128). |#fig_caption|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018635(177532)|#gene_synonym
##EndOfRet##
23705068_92|23705068|21893|#section_info|0:0|RNAi of nprl-3 by dsRNA injection also rescued the L1 arrest of elo-5(-) and cgt-1(-);cgt-3(-) animals (Figure 3C), indicating that ku540 is likely a partial loss-of-function or reduction-of-function mutation. |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_93|23705068|21893|#section_info|0:0|RNAi of nprl-3 by dsRNA injection also rescued the L1 arrest of elo-5(-) and cgt-1(-);cgt-3(-) animals (Figure 3C), indicating that ku540 is likely a partial loss-of-function or reduction-of-function mutation. |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_94|23705068|21893|#section_info|0:0|RNAi of nprl-3 by dsRNA injection also rescued the L1 arrest of elo-5(-) and cgt-1(-);cgt-3(-) animals (Figure 3C), indicating that ku540 is likely a partial loss-of-function or reduction-of-function mutation. |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|cgt-2(181790)|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_95|23705068|21893|#section_info|0:0|RNAi of nprl-3 by dsRNA injection also rescued the L1 arrest of elo-5(-) and cgt-1(-);cgt-3(-) animals (Figure 3C), indicating that ku540 is likely a partial loss-of-function or reduction-of-function mutation. |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00017625(181790)|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_96|23705068|21893|#section_info|0:0|RNAi of nprl-3 by dsRNA injection also rescued the L1 arrest of elo-5(-) and cgt-1(-);cgt-3(-) animals (Figure 3C), indicating that ku540 is likely a partial loss-of-function or reduction-of-function mutation. |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|cgt-1(188169)|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_97|23705068|21893|#section_info|0:0|RNAi of nprl-3 by dsRNA injection also rescued the L1 arrest of elo-5(-) and cgt-1(-);cgt-3(-) animals (Figure 3C), indicating that ku540 is likely a partial loss-of-function or reduction-of-function mutation. |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00011517(188169)|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_98|23705068|21893|#section_info|0:0|RNAi of nprl-3 by dsRNA injection also rescued the L1 arrest of elo-5(-) and cgt-1(-);cgt-3(-) animals (Figure 3C), indicating that ku540 is likely a partial loss-of-function or reduction-of-function mutation. |#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_99|23705068|21893|#section_info|0:0|RNAi of nprl-3 by dsRNA injection also rescued the L1 arrest of elo-5(-) and cgt-1(-);cgt-3(-) animals (Figure 3C), indicating that ku540 is likely a partial loss-of-function or reduction-of-function mutation. |#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_100|23705068|21893|#section_info|0:0|RNAi of nprl-3 by dsRNA injection also rescued the L1 arrest of elo-5(-) and cgt-1(-);cgt-3(-) animals (Figure 3C), indicating that ku540 is likely a partial loss-of-function or reduction-of-function mutation. |#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_101|23705068|21893|#section_info|0:0|RNAi of nprl-3 by dsRNA injection also rescued the L1 arrest of elo-5(-) and cgt-1(-);cgt-3(-) animals (Figure 3C), indicating that ku540 is likely a partial loss-of-function or reduction-of-function mutation. |#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_102|23705068|22751|#section_info|0:0|We found that RNAi by dsRNA injection of the C. elegans NPR2 homolog nprl-2 (F49E8.1) also suppressed the developmental arrest of elo-5(-) larvae (Figure 3C).|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-2(177532)|#gene_synonym
0.64	23705068_440|23705068|69353|Additional files|0:0|Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_132|23705068|25881|Results|0:0|Without C17ISO supplementation, RNAi knockdown of multiple TORC1 components reverted elo-5(-);nprl-3(ku540) animals to larval arrest.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_397|23705068|65255|Additional files|0:0|Systematic functional analysis of the Caenorhabditis elegans genome using RNAi|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_103|23705068|22751|#section_info|0:0|We found that RNAi by dsRNA injection of the C. elegans NPR2 homolog nprl-2 (F49E8.1) also suppressed the developmental arrest of elo-5(-) larvae (Figure 3C).|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018635(177532)|#gene_synonym
0.64	23705068_440|23705068|69353|Additional files|0:0|Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_132|23705068|25881|Results|0:0|Without C17ISO supplementation, RNAi knockdown of multiple TORC1 components reverted elo-5(-);nprl-3(ku540) animals to larval arrest.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_397|23705068|65255|Additional files|0:0|Systematic functional analysis of the Caenorhabditis elegans genome using RNAi|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_104|23705068|22751|#section_info|0:0|We found that RNAi by dsRNA injection of the C. elegans NPR2 homolog nprl-2 (F49E8.1) also suppressed the developmental arrest of elo-5(-) larvae (Figure 3C).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.64	23705068_440|23705068|69353|Additional files|0:0|Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_132|23705068|25881|Results|0:0|Without C17ISO supplementation, RNAi knockdown of multiple TORC1 components reverted elo-5(-);nprl-3(ku540) animals to larval arrest.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_397|23705068|65255|Additional files|0:0|Systematic functional analysis of the Caenorhabditis elegans genome using RNAi|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_105|23705068|22751|#section_info|0:0|We found that RNAi by dsRNA injection of the C. elegans NPR2 homolog nprl-2 (F49E8.1) also suppressed the developmental arrest of elo-5(-) larvae (Figure 3C).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.64	23705068_440|23705068|69353|Additional files|0:0|Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_132|23705068|25881|Results|0:0|Without C17ISO supplementation, RNAi knockdown of multiple TORC1 components reverted elo-5(-);nprl-3(ku540) animals to larval arrest.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_397|23705068|65255|Additional files|0:0|Systematic functional analysis of the Caenorhabditis elegans genome using RNAi|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_106|23705068|22751|#section_info|0:0|This suggested that NPRL-2 and NPRL-3 in C. elegans may also function in a complex to negatively impact mmBCFA/d17iso-GlcCer-mediated L1 growth.|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|NONE|GOA|nprl-2(177532)|#gene_synonym
0.61	23705068_438|23705068|69114|Additional files|0:0|P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_107|23705068|22751|#section_info|0:0|This suggested that NPRL-2 and NPRL-3 in C. elegans may also function in a complex to negatively impact mmBCFA/d17iso-GlcCer-mediated L1 growth.|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|NONE|GOA|WBGene00018635(177532)|#gene_synonym
0.61	23705068_438|23705068|69114|Additional files|0:0|P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_108|23705068|22751|#section_info|0:0|This suggested that NPRL-2 and NPRL-3 in C. elegans may also function in a complex to negatively impact mmBCFA/d17iso-GlcCer-mediated L1 growth.|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|NONE|GOA|nprl-3(185331)|#gene_synonym
0.61	23705068_438|23705068|69114|Additional files|0:0|P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_109|23705068|22751|#section_info|0:0|This suggested that NPRL-2 and NPRL-3 in C. elegans may also function in a complex to negatively impact mmBCFA/d17iso-GlcCer-mediated L1 growth.|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|NONE|GOA|WBGene00018072(185331)|#gene_synonym
0.61	23705068_438|23705068|69114|Additional files|0:0|P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_110|23705068|23313|#section_info|0:0|NPRL-3 regulates d17iso-GlcCer function in L1 growth by repressing TORC1 activity|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|NONE|GOA|nprl-3(185331)|#gene_synonym
0.66	23705068_207|23705068|44224|Discussion|0:0|How does d17iso-GlcCer regulate the activity of TORC1?|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_127|23705068|24749|Results|0:0|Intact TORC1 function is necessary for mmBCFA-mediated growth regulation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_438|23705068|69114|Additional files|0:0|P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_111|23705068|23313|#section_info|0:0|NPRL-3 regulates d17iso-GlcCer function in L1 growth by repressing TORC1 activity|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|NONE|GOA|WBGene00018072(185331)|#gene_synonym
0.66	23705068_207|23705068|44224|Discussion|0:0|How does d17iso-GlcCer regulate the activity of TORC1?|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_127|23705068|24749|Results|0:0|Intact TORC1 function is necessary for mmBCFA-mediated growth regulation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_438|23705068|69114|Additional files|0:0|P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_112|23705068|23313|#section_info|0:0|NPRL-3 regulates d17iso-GlcCer function in L1 growth by repressing TORC1 activity|#main_body|GO:0032007|negative regulation of TOR signaling cascade|#go_definition|NONE|GOA|nprl-3(185331)|#gene_synonym
0.66	23705068_207|23705068|44224|Discussion|0:0|How does d17iso-GlcCer regulate the activity of TORC1?|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_127|23705068|24749|Results|0:0|Intact TORC1 function is necessary for mmBCFA-mediated growth regulation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_438|23705068|69114|Additional files|0:0|P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_113|23705068|23313|#section_info|0:0|NPRL-3 regulates d17iso-GlcCer function in L1 growth by repressing TORC1 activity|#main_body|GO:0032007|negative regulation of TOR signaling cascade|#go_definition|NONE|GOA|WBGene00018072(185331)|#gene_synonym
0.66	23705068_207|23705068|44224|Discussion|0:0|How does d17iso-GlcCer regulate the activity of TORC1?|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_127|23705068|24749|Results|0:0|Intact TORC1 function is necessary for mmBCFA-mediated growth regulation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_438|23705068|69114|Additional files|0:0|P-type ATPase TAT-2 negatively regulates monomethyl branched-chain fatty acid mediated function in post-embryonic growth and development in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_114|23705068|23395|#section_info|0:0|We thus explored the possibility that TOR Complex 1 (TORC1) is also the downstream target of NPRL2/3 in growth regulation in C. elegans and that nprl-3(ku540) alleviates d17iso-GlcCer deficiency-induced growth arrest by activating the TORC1 pathway.|#main_body|GO:0040015|negative regulation of multicellular organism growth|#go_definition|NONE|GOA|nprl-3(185331)|#gene_synonym
0.71	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_165|23705068|33611|Results|0:0|(2010), in which fusion of one of the TOR binding partners, Raptor, with a C-terminal lysosome localization signal from Rap-1 can localize mTOR to the lysosome and thus constitutively activate the TOR pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_199|23705068|41772|Discussion|0:0|Third, the TOR pathway is down-regulated by inhibiting the abnormally high GlcCer biosynthesis in polycystic kidney disease in mouse models (Natoli et al., 2010), suggesting a possible conserved link between GlcCer and TOR activities.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_409|23705068|66543|Additional files|0:0|TOR deficiency in C. elegans causes developmental arrest and intestinal atrophy by inhibition of mRNA translation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_192|23705068|41772|Discussion|0:0|First, the components of TORC1 are conserved between C. elegans and mammals.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_421|23705068|67794|Additional files|0:0|A genome-wide screen for regulators of TORC1 in response to amino acid starvation reveals a conserved Npr2/3 complex|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_127|23705068|24749|Results|0:0|Intact TORC1 function is necessary for mmBCFA-mediated growth regulation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_193|23705068|41772|Discussion|0:0|The NPRL-3 protein we identified in this pathway is conserved in all eukaryotes, and its negative regulatory role on TOR has been characterized in budding yeast (Neklesa and Davis, 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_196|23705068|41772|Discussion|0:0|This property is consistent with the role of this complex in repressing TOR-mediated growth regulation that was identified in budding yeast and this study.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_206|23705068|44187|Discussion|0:0|Activation of TORC1 by d17iso-GlcCer|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_141|23705068|28954|Results|0:0|TORC1 activation is sufficient for mmBCFAs-mediated growth regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_176|23705068|38632|Discussion|0:0|This discovery reveals a specific link between lipids and the TORC1 signaling pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_402|23705068|65742|Additional files|0:0|A branched-chain fatty acid is involved in post-embryonic growth control in parallel to the insulin receptor pathway and its biosynthesis is feedback-regulated in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_115|23705068|23395|#section_info|0:0|We thus explored the possibility that TOR Complex 1 (TORC1) is also the downstream target of NPRL2/3 in growth regulation in C. elegans and that nprl-3(ku540) alleviates d17iso-GlcCer deficiency-induced growth arrest by activating the TORC1 pathway.|#main_body|GO:0040015|negative regulation of multicellular organism growth|#go_definition|NONE|GOA|WBGene00018072(185331)|#gene_synonym
0.71	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_165|23705068|33611|Results|0:0|(2010), in which fusion of one of the TOR binding partners, Raptor, with a C-terminal lysosome localization signal from Rap-1 can localize mTOR to the lysosome and thus constitutively activate the TOR pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_199|23705068|41772|Discussion|0:0|Third, the TOR pathway is down-regulated by inhibiting the abnormally high GlcCer biosynthesis in polycystic kidney disease in mouse models (Natoli et al., 2010), suggesting a possible conserved link between GlcCer and TOR activities.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_409|23705068|66543|Additional files|0:0|TOR deficiency in C. elegans causes developmental arrest and intestinal atrophy by inhibition of mRNA translation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_192|23705068|41772|Discussion|0:0|First, the components of TORC1 are conserved between C. elegans and mammals.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_421|23705068|67794|Additional files|0:0|A genome-wide screen for regulators of TORC1 in response to amino acid starvation reveals a conserved Npr2/3 complex|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_127|23705068|24749|Results|0:0|Intact TORC1 function is necessary for mmBCFA-mediated growth regulation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_193|23705068|41772|Discussion|0:0|The NPRL-3 protein we identified in this pathway is conserved in all eukaryotes, and its negative regulatory role on TOR has been characterized in budding yeast (Neklesa and Davis, 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_196|23705068|41772|Discussion|0:0|This property is consistent with the role of this complex in repressing TOR-mediated growth regulation that was identified in budding yeast and this study.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_206|23705068|44187|Discussion|0:0|Activation of TORC1 by d17iso-GlcCer|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_141|23705068|28954|Results|0:0|TORC1 activation is sufficient for mmBCFAs-mediated growth regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_176|23705068|38632|Discussion|0:0|This discovery reveals a specific link between lipids and the TORC1 signaling pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_402|23705068|65742|Additional files|0:0|A branched-chain fatty acid is involved in post-embryonic growth control in parallel to the insulin receptor pathway and its biosynthesis is feedback-regulated in C. elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_116|23705068|23967|#section_info|0:0|We reasoned that if reducing nprl-2/3 activity rescued elo-5(-) L1 growth by up-regulating the TORC1 pathway in C. elegans, then reducing, but not eliminating, TORC1 activity may reverse the rescue effects of nprl-3(ku540) on elo-5(-) mutant background.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.68	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_117|23705068|23967|#section_info|0:0|We reasoned that if reducing nprl-2/3 activity rescued elo-5(-) L1 growth by up-regulating the TORC1 pathway in C. elegans, then reducing, but not eliminating, TORC1 activity may reverse the rescue effects of nprl-3(ku540) on elo-5(-) mutant background.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.68	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_118|23705068|23967|#section_info|0:0|We reasoned that if reducing nprl-2/3 activity rescued elo-5(-) L1 growth by up-regulating the TORC1 pathway in C. elegans, then reducing, but not eliminating, TORC1 activity may reverse the rescue effects of nprl-3(ku540) on elo-5(-) mutant background.|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-2(177532)|#gene_synonym
0.68	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_119|23705068|23967|#section_info|0:0|We reasoned that if reducing nprl-2/3 activity rescued elo-5(-) L1 growth by up-regulating the TORC1 pathway in C. elegans, then reducing, but not eliminating, TORC1 activity may reverse the rescue effects of nprl-3(ku540) on elo-5(-) mutant background.|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018635(177532)|#gene_synonym
0.68	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_120|23705068|23967|#section_info|0:0|We reasoned that if reducing nprl-2/3 activity rescued elo-5(-) L1 growth by up-regulating the TORC1 pathway in C. elegans, then reducing, but not eliminating, TORC1 activity may reverse the rescue effects of nprl-3(ku540) on elo-5(-) mutant background.|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
0.68	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_121|23705068|23967|#section_info|0:0|We reasoned that if reducing nprl-2/3 activity rescued elo-5(-) L1 growth by up-regulating the TORC1 pathway in C. elegans, then reducing, but not eliminating, TORC1 activity may reverse the rescue effects of nprl-3(ku540) on elo-5(-) mutant background.|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
0.68	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_122|23705068|23967|#section_info|0:0|We reasoned that if reducing nprl-2/3 activity rescued elo-5(-) L1 growth by up-regulating the TORC1 pathway in C. elegans, then reducing, but not eliminating, TORC1 activity may reverse the rescue effects of nprl-3(ku540) on elo-5(-) mutant background.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.68	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_123|23705068|23967|#section_info|0:0|We reasoned that if reducing nprl-2/3 activity rescued elo-5(-) L1 growth by up-regulating the TORC1 pathway in C. elegans, then reducing, but not eliminating, TORC1 activity may reverse the rescue effects of nprl-3(ku540) on elo-5(-) mutant background.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.68	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_124|23705068|23967|#section_info|0:0|We reasoned that if reducing nprl-2/3 activity rescued elo-5(-) L1 growth by up-regulating the TORC1 pathway in C. elegans, then reducing, but not eliminating, TORC1 activity may reverse the rescue effects of nprl-3(ku540) on elo-5(-) mutant background.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.68	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_125|23705068|23967|#section_info|0:0|We reasoned that if reducing nprl-2/3 activity rescued elo-5(-) L1 growth by up-regulating the TORC1 pathway in C. elegans, then reducing, but not eliminating, TORC1 activity may reverse the rescue effects of nprl-3(ku540) on elo-5(-) mutant background.|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.68	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_126|23705068|23967|#section_info|0:0|We reasoned that if reducing nprl-2/3 activity rescued elo-5(-) L1 growth by up-regulating the TORC1 pathway in C. elegans, then reducing, but not eliminating, TORC1 activity may reverse the rescue effects of nprl-3(ku540) on elo-5(-) mutant background.|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-2(177532)|#gene_synonym
0.68	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_127|23705068|23967|#section_info|0:0|We reasoned that if reducing nprl-2/3 activity rescued elo-5(-) L1 growth by up-regulating the TORC1 pathway in C. elegans, then reducing, but not eliminating, TORC1 activity may reverse the rescue effects of nprl-3(ku540) on elo-5(-) mutant background.|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018635(177532)|#gene_synonym
0.68	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_128|23705068|23967|#section_info|0:0|We reasoned that if reducing nprl-2/3 activity rescued elo-5(-) L1 growth by up-regulating the TORC1 pathway in C. elegans, then reducing, but not eliminating, TORC1 activity may reverse the rescue effects of nprl-3(ku540) on elo-5(-) mutant background.|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
0.68	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_129|23705068|23967|#section_info|0:0|We reasoned that if reducing nprl-2/3 activity rescued elo-5(-) L1 growth by up-regulating the TORC1 pathway in C. elegans, then reducing, but not eliminating, TORC1 activity may reverse the rescue effects of nprl-3(ku540) on elo-5(-) mutant background.|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
0.68	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_130|23705068|26446|#section_info|0:0|While nprl-3(ku540) effectively suppressed the L1 arrest phenotype of elo-5(-), the suppression dramatically decreased when raga-1(RNAi) or rheb-1(RNAi) were applied to the elo-5(-) nprl-3(ku540) double mutant (Table 1).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.66	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_271|23705068|51585|Materials and methods|0:0|In our previously published screen (Seamen et al., 2009), we isolated three mutations in tat-2 that can suppress elo-5(-)-induced L1 arrest in the presence of C13ISO, or temporarily suppress the L1 arrest for one generation without C13ISO supplement.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_131|23705068|26446|#section_info|0:0|While nprl-3(ku540) effectively suppressed the L1 arrest phenotype of elo-5(-), the suppression dramatically decreased when raga-1(RNAi) or rheb-1(RNAi) were applied to the elo-5(-) nprl-3(ku540) double mutant (Table 1).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.66	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_271|23705068|51585|Materials and methods|0:0|In our previously published screen (Seamen et al., 2009), we isolated three mutations in tat-2 that can suppress elo-5(-)-induced L1 arrest in the presence of C13ISO, or temporarily suppress the L1 arrest for one generation without C13ISO supplement.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_132|23705068|26446|#section_info|0:0|While nprl-3(ku540) effectively suppressed the L1 arrest phenotype of elo-5(-), the suppression dramatically decreased when raga-1(RNAi) or rheb-1(RNAi) were applied to the elo-5(-) nprl-3(ku540) double mutant (Table 1).|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
0.66	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_271|23705068|51585|Materials and methods|0:0|In our previously published screen (Seamen et al., 2009), we isolated three mutations in tat-2 that can suppress elo-5(-)-induced L1 arrest in the presence of C13ISO, or temporarily suppress the L1 arrest for one generation without C13ISO supplement.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_133|23705068|26446|#section_info|0:0|While nprl-3(ku540) effectively suppressed the L1 arrest phenotype of elo-5(-), the suppression dramatically decreased when raga-1(RNAi) or rheb-1(RNAi) were applied to the elo-5(-) nprl-3(ku540) double mutant (Table 1).|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
0.66	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_271|23705068|51585|Materials and methods|0:0|In our previously published screen (Seamen et al., 2009), we isolated three mutations in tat-2 that can suppress elo-5(-)-induced L1 arrest in the presence of C13ISO, or temporarily suppress the L1 arrest for one generation without C13ISO supplement.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_134|23705068|26446|#section_info|0:0|While nprl-3(ku540) effectively suppressed the L1 arrest phenotype of elo-5(-), the suppression dramatically decreased when raga-1(RNAi) or rheb-1(RNAi) were applied to the elo-5(-) nprl-3(ku540) double mutant (Table 1).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|raga-1(174726)|#gene_synonym
0.66	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_271|23705068|51585|Materials and methods|0:0|In our previously published screen (Seamen et al., 2009), we isolated three mutations in tat-2 that can suppress elo-5(-)-induced L1 arrest in the presence of C13ISO, or temporarily suppress the L1 arrest for one generation without C13ISO supplement.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_135|23705068|26446|#section_info|0:0|While nprl-3(ku540) effectively suppressed the L1 arrest phenotype of elo-5(-), the suppression dramatically decreased when raga-1(RNAi) or rheb-1(RNAi) were applied to the elo-5(-) nprl-3(ku540) double mutant (Table 1).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00006414(174726)|#gene_synonym
0.66	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_271|23705068|51585|Materials and methods|0:0|In our previously published screen (Seamen et al., 2009), we isolated three mutations in tat-2 that can suppress elo-5(-)-induced L1 arrest in the presence of C13ISO, or temporarily suppress the L1 arrest for one generation without C13ISO supplement.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_136|23705068|26446|#section_info|0:0|While nprl-3(ku540) effectively suppressed the L1 arrest phenotype of elo-5(-), the suppression dramatically decreased when raga-1(RNAi) or rheb-1(RNAi) were applied to the elo-5(-) nprl-3(ku540) double mutant (Table 1).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|rheb-1(176327)|#gene_synonym
0.66	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_271|23705068|51585|Materials and methods|0:0|In our previously published screen (Seamen et al., 2009), we isolated three mutations in tat-2 that can suppress elo-5(-)-induced L1 arrest in the presence of C13ISO, or temporarily suppress the L1 arrest for one generation without C13ISO supplement.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_137|23705068|26446|#section_info|0:0|While nprl-3(ku540) effectively suppressed the L1 arrest phenotype of elo-5(-), the suppression dramatically decreased when raga-1(RNAi) or rheb-1(RNAi) were applied to the elo-5(-) nprl-3(ku540) double mutant (Table 1).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00010038(176327)|#gene_synonym
0.66	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_271|23705068|51585|Materials and methods|0:0|In our previously published screen (Seamen et al., 2009), we isolated three mutations in tat-2 that can suppress elo-5(-)-induced L1 arrest in the presence of C13ISO, or temporarily suppress the L1 arrest for one generation without C13ISO supplement.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_138|23705068|26446|#section_info|0:0|This indicates that the rescue effect of nprl-3(ku540) on elo-5(-) depends on intact TORC1 activity.|#main_body|GO:0032006|regulation of TOR signaling cascade|#go_definition|NONE|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_139|23705068|26446|#section_info|0:0|This indicates that the rescue effect of nprl-3(ku540) on elo-5(-) depends on intact TORC1 activity.|#main_body|GO:0032006|regulation of TOR signaling cascade|#go_definition|NONE|GOA|WBGene00018072(185331)|#gene_synonym
##EndOfRet##
23705068_140|23705068|26446|#section_info|0:0|This indicates that the rescue effect of nprl-3(ku540) on elo-5(-) depends on intact TORC1 activity.|#main_body|GO:0032006|regulation of TOR signaling cascade|#go_definition|NONE|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
23705068_141|23705068|26446|#section_info|0:0|This indicates that the rescue effect of nprl-3(ku540) on elo-5(-) depends on intact TORC1 activity.|#main_body|GO:0032006|regulation of TOR signaling cascade|#go_definition|NONE|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
23705068_142|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0031929|TOR signaling cascade|#go_definition|IGI|GOA|raga-1(174726)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_143|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0031929|TOR signaling cascade|#go_definition|IGI|GOA|WBGene00006414(174726)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_144|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0031929|TOR signaling cascade|#go_definition|IGI|GOA|rheb-1(176327)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_145|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0031929|TOR signaling cascade|#go_definition|IGI|GOA|WBGene00010038(176327)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_146|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0032007|negative regulation of TOR signaling cascade|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_147|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0032007|negative regulation of TOR signaling cascade|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_148|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0032007|negative regulation of TOR signaling cascade|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_149|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0032007|negative regulation of TOR signaling cascade|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_150|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0032008|positive regulation of TOR signaling cascade|#go_definition|IGI|GOA|elo-5(177320)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_151|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0032008|positive regulation of TOR signaling cascade|#go_definition|IGI|GOA|WBGene00001243(177320)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_152|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0032008|positive regulation of TOR signaling cascade|#go_definition|IGI|GOA|elo-5(177320)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_153|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0032008|positive regulation of TOR signaling cascade|#go_definition|IGI|GOA|WBGene00001243(177320)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_154|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_155|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_156|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_157|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_158|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|raga-1(174726)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_159|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00006414(174726)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_160|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|rheb-1(176327)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_161|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00010038(176327)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_162|23705068|26768|#section_info|0:0|This result further indicates that the reversal of the nprl-3(ku540) suppression by raga-1(RNAi) or rheb-1(RNAi) depends on mmBCFA deficiency. In other words, reducing, but not eliminating, TORC1 activity neutralized the effect of nprl-3(ku540) and restored the L1 arrest phenotype of elo-5(-).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|ife-2(180393)|#gene_synonym
0.72	23705068_146|23705068|30355|Results|0:0|Animals with C17ISO supplement reached adulthood (arrowhead), suggesting that the arrest depends on mmBCFA deficiency and is not caused by RNAi itself.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_276|23705068|51585|Materials and methods|0:0|(1) Unlike feeding d17iso-SPA or the downstream suppressor nprl-3(ku540) that fully suppresses mmBCFA deficiency [elo-5(-)]-induced L1 arrest (this study), tat-2(-)does not bypass the requirement of mmBCFAs for growth for more than one generation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_163|23705068|26768|#section_info|0:0|We found that elo-5(-) nprl-3(ku540) animals treated with ife-2(RNAi) or rsks-1(RNAi), with or without C17ISO supplement, yielded results similar to those obtained with raga-1(RNAi) and rheb-1(RNAi) (Table 1). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00002060(180393)|#gene_synonym
0.71	23705068_296|23705068|55482|Materials and methods|0:0|All RNAi by feeding, except cgt-3(RNAi) and let-363(RNAi), used bacterial clones from the MRC RNAi library (Kamath et al., 2003) or the ORF-RNAi Library (Open Biosystems) (Figures 1-3).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_238|23705068|48274|Materials and methods|0:0|Using RNAi.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_312|23705068|57260|Materials and methods|0:0|In our experiments, the usage of the heterozygous elo-5(-) nprl-3(ku540)/nT1[qIs51] animals for the RNAi knockdown experiment allowed us to exclude the potential negative effect from RNAi treatment of TORC1 components and TORC1 target genes themselves.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_132|23705068|25881|Results|0:0|Without C17ISO supplementation, RNAi knockdown of multiple TORC1 components reverted elo-5(-);nprl-3(ku540) animals to larval arrest.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_164|23705068|26768|#section_info|0:0|We found that elo-5(-) nprl-3(ku540) animals treated with ife-2(RNAi) or rsks-1(RNAi), with or without C17ISO supplement, yielded results similar to those obtained with raga-1(RNAi) and rheb-1(RNAi) (Table 1). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|rsks-1(176554)|#gene_synonym
0.71	23705068_296|23705068|55482|Materials and methods|0:0|All RNAi by feeding, except cgt-3(RNAi) and let-363(RNAi), used bacterial clones from the MRC RNAi library (Kamath et al., 2003) or the ORF-RNAi Library (Open Biosystems) (Figures 1-3).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_238|23705068|48274|Materials and methods|0:0|Using RNAi.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_312|23705068|57260|Materials and methods|0:0|In our experiments, the usage of the heterozygous elo-5(-) nprl-3(ku540)/nT1[qIs51] animals for the RNAi knockdown experiment allowed us to exclude the potential negative effect from RNAi treatment of TORC1 components and TORC1 target genes themselves.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_132|23705068|25881|Results|0:0|Without C17ISO supplementation, RNAi knockdown of multiple TORC1 components reverted elo-5(-);nprl-3(ku540) animals to larval arrest.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_165|23705068|26768|#section_info|0:0|We found that elo-5(-) nprl-3(ku540) animals treated with ife-2(RNAi) or rsks-1(RNAi), with or without C17ISO supplement, yielded results similar to those obtained with raga-1(RNAi) and rheb-1(RNAi) (Table 1). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00012929(176554)|#gene_synonym
0.71	23705068_296|23705068|55482|Materials and methods|0:0|All RNAi by feeding, except cgt-3(RNAi) and let-363(RNAi), used bacterial clones from the MRC RNAi library (Kamath et al., 2003) or the ORF-RNAi Library (Open Biosystems) (Figures 1-3).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_238|23705068|48274|Materials and methods|0:0|Using RNAi.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_312|23705068|57260|Materials and methods|0:0|In our experiments, the usage of the heterozygous elo-5(-) nprl-3(ku540)/nT1[qIs51] animals for the RNAi knockdown experiment allowed us to exclude the potential negative effect from RNAi treatment of TORC1 components and TORC1 target genes themselves.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_132|23705068|25881|Results|0:0|Without C17ISO supplementation, RNAi knockdown of multiple TORC1 components reverted elo-5(-);nprl-3(ku540) animals to larval arrest.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_166|23705068|27339|#section_info|0:0|To further examine whether the rescuing effect of nprl-3(ku540) on elo-5(-) L1 arrest required the canonical activity of TORC1, we used RNAi to knock down C. elegans orthologs of elf4E (ife-2) and p70S6K(rsks-1), two well-known downstream targets of TORC1 (Long et al., 2002; Syntichaki et al., 2007; Anjum and Blenis, 2008; Sheaffer et al., 2008).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.81	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	23705068_177|23705068|38632|Discussion|0:0|Both ceramide and TORC1 have been individually implicated for roles in stress response, apoptosis, cancers, and other cellular processes by studies in C. elegans and mammals (Hannun and Obeid, 2008; Hansen et al., 2008; He and Klionsky, 2009; Howell and Manning, 2011; Laplante and Sabatini, 2012; Menuz et al., 2009; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	23705068_25|23705068|3334|Introduction|0:0|The target of rapamycin (TOR) complexes (TORC1 and TORC2) are known to function in sensing various nutrient signals (Ma and Blenis, 2009; Laplante and Sabatini, 2012; Zoncu et al., 2012), and their roles are connected to growth, metabolism, stress responses, and cancers (Hansen et al., 2008; He and Klionsky, 2009; Howell and Manning, 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	23705068_30|23705068|4417|Introduction|0:0|An insulin/IGF-1 receptor signaling (IIS) pathway plays a critical role in the induction of L1 diapause and survival of the developmentally arrested animals (Gems et al., 1998; Baugh and Sternberg, 2006; Kniazeva et al., 2008; Lee and Ashrafi, 2008; Jones et al., 2009; Soukas et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	23705068_31|23705068|4417|Introduction|0:0|Moreover, TOR complexes have also been indicated to play prominent roles in regulating postembryonic growth and lifespan in C. elegans (Vellai et al., 2003; Syntichaki et al., 2007; Hansen et al., 2008; Honjoh et al., 2009; Lucanic et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_185|23705068|40853|Discussion|0:0|In C. elegans, both the IIS and DAF-7/TGF-beta pathways have been shown to play critical roles in the regulation of postembryonic growth and development in response to nutrient/food availability (Baugh and Sternberg, 2006; Mukhopadhyay and Tissenbaum, 2007; Fielenbach and Antebi, 2008; Lee and Ashrafi, 2008; Jones et al., 2009; Soukas et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	23705068_307|23705068|56480|Materials and methods|0:0|Furthermore, results from those references and our experiments have shown RNAi feeding of these genes did not reproduce the strong larval lethal phenotype (Hansen et al., 2007; Syntichaki et al., 2007; Lemire et al., 2009; Ching et al., 2010; Polley and Fay, 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_166|23705068|33611|Results|0:0|Both Rap-1 and Raptor proteins are highly conserved in C. elegans (encoded by rap-1 and daf-15; Long et al., 2002; Pellis-van Berkel et al., 2005).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_211|23705068|44224|Discussion|0:0|By examining lysosomal markers LMP-1::GFP (Artal-Sanz et al., 2006; O'Rourke et al., 2009; Rabbitts et al., 2008), GLO-1::GFP (Schroeder et al., 2007; Zhang et al., 2010), and Neutral red (Long et al., 2002), we did not observe obvious defects in lysosome formation in elo-5(-) mutants (Figure 4:figure supplements 4 and 5).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	23705068_195|23705068|41772|Discussion|0:0|NPRL2 (human ortholog of NPR2) and DEPDC5 (human ortholog of IML1) have been reported to function as tumor suppressors (Merrill et al., 1997; Li et al., 2004; Neklesa and Davis, 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_197|23705068|41772|Discussion|0:0|Second, a role for GlcCer in nutrient sensing is consistent with studies showing that ceramide and sphingolipids play roles in cell signaling and growth control in both invertebrates and mammals (Deng et al., 2008; Hannun and Obeid, 2008; Menuz et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_213|23705068|44224|Discussion|0:0|One possible mechanism is that d17iso-GlcCer acts through the V-ATPase pathway, since the lysosomal V-ATPase has been shown to be stimulated by GlcCer and to play an essential role in TORC1 activation in studies using tissue culture cells (van der Poel et al., 2011; Zoncu et al., 2011; Bar-Peled et al., 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_38|23705068|6227|Introduction|0:0|Further genetic analysis suggested that this developmental arrest is independent of the IIS pathway (Kniazeva et al., 2004, 2008).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_212|23705068|44224|Discussion|0:0|Major defects in lysosome formation would also be inconsistent with our genetic suppression data and previous studies on GlcCer by others (Entchev et al., 2008; van der Poel et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_297|23705068|55482|Materials and methods|0:0|cgt-3(RNAi) and let-363(RNAi) constructs were made as described (Marza et al., 2009; Honjoh et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_312|23705068|57260|Materials and methods|0:0|In our experiments, the usage of the heterozygous elo-5(-) nprl-3(ku540)/nT1[qIs51] animals for the RNAi knockdown experiment allowed us to exclude the potential negative effect from RNAi treatment of TORC1 components and TORC1 target genes themselves.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_183|23705068|39744|Discussion|0:0|There are several reported leucine-sensing mechanisms, based on studies using tissue culture cells (Bonfils et al., 2012; Duran et al., 2012; Han et al., 2012; Zoncu et al., 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_304|23705068|56415|Materials and methods|0:0|Feeding RNAi analysis of TORC1 components and downstream targets|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_167|23705068|27339|#section_info|0:0|To further examine whether the rescuing effect of nprl-3(ku540) on elo-5(-) L1 arrest required the canonical activity of TORC1, we used RNAi to knock down C. elegans orthologs of elf4E (ife-2) and p70S6K(rsks-1), two well-known downstream targets of TORC1 (Long et al., 2002; Syntichaki et al., 2007; Anjum and Blenis, 2008; Sheaffer et al., 2008).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.81	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	23705068_177|23705068|38632|Discussion|0:0|Both ceramide and TORC1 have been individually implicated for roles in stress response, apoptosis, cancers, and other cellular processes by studies in C. elegans and mammals (Hannun and Obeid, 2008; Hansen et al., 2008; He and Klionsky, 2009; Howell and Manning, 2011; Laplante and Sabatini, 2012; Menuz et al., 2009; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	23705068_25|23705068|3334|Introduction|0:0|The target of rapamycin (TOR) complexes (TORC1 and TORC2) are known to function in sensing various nutrient signals (Ma and Blenis, 2009; Laplante and Sabatini, 2012; Zoncu et al., 2012), and their roles are connected to growth, metabolism, stress responses, and cancers (Hansen et al., 2008; He and Klionsky, 2009; Howell and Manning, 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	23705068_30|23705068|4417|Introduction|0:0|An insulin/IGF-1 receptor signaling (IIS) pathway plays a critical role in the induction of L1 diapause and survival of the developmentally arrested animals (Gems et al., 1998; Baugh and Sternberg, 2006; Kniazeva et al., 2008; Lee and Ashrafi, 2008; Jones et al., 2009; Soukas et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	23705068_31|23705068|4417|Introduction|0:0|Moreover, TOR complexes have also been indicated to play prominent roles in regulating postembryonic growth and lifespan in C. elegans (Vellai et al., 2003; Syntichaki et al., 2007; Hansen et al., 2008; Honjoh et al., 2009; Lucanic et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_185|23705068|40853|Discussion|0:0|In C. elegans, both the IIS and DAF-7/TGF-beta pathways have been shown to play critical roles in the regulation of postembryonic growth and development in response to nutrient/food availability (Baugh and Sternberg, 2006; Mukhopadhyay and Tissenbaum, 2007; Fielenbach and Antebi, 2008; Lee and Ashrafi, 2008; Jones et al., 2009; Soukas et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	23705068_307|23705068|56480|Materials and methods|0:0|Furthermore, results from those references and our experiments have shown RNAi feeding of these genes did not reproduce the strong larval lethal phenotype (Hansen et al., 2007; Syntichaki et al., 2007; Lemire et al., 2009; Ching et al., 2010; Polley and Fay, 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_166|23705068|33611|Results|0:0|Both Rap-1 and Raptor proteins are highly conserved in C. elegans (encoded by rap-1 and daf-15; Long et al., 2002; Pellis-van Berkel et al., 2005).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_211|23705068|44224|Discussion|0:0|By examining lysosomal markers LMP-1::GFP (Artal-Sanz et al., 2006; O'Rourke et al., 2009; Rabbitts et al., 2008), GLO-1::GFP (Schroeder et al., 2007; Zhang et al., 2010), and Neutral red (Long et al., 2002), we did not observe obvious defects in lysosome formation in elo-5(-) mutants (Figure 4:figure supplements 4 and 5).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	23705068_195|23705068|41772|Discussion|0:0|NPRL2 (human ortholog of NPR2) and DEPDC5 (human ortholog of IML1) have been reported to function as tumor suppressors (Merrill et al., 1997; Li et al., 2004; Neklesa and Davis, 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_197|23705068|41772|Discussion|0:0|Second, a role for GlcCer in nutrient sensing is consistent with studies showing that ceramide and sphingolipids play roles in cell signaling and growth control in both invertebrates and mammals (Deng et al., 2008; Hannun and Obeid, 2008; Menuz et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_213|23705068|44224|Discussion|0:0|One possible mechanism is that d17iso-GlcCer acts through the V-ATPase pathway, since the lysosomal V-ATPase has been shown to be stimulated by GlcCer and to play an essential role in TORC1 activation in studies using tissue culture cells (van der Poel et al., 2011; Zoncu et al., 2011; Bar-Peled et al., 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_38|23705068|6227|Introduction|0:0|Further genetic analysis suggested that this developmental arrest is independent of the IIS pathway (Kniazeva et al., 2004, 2008).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_212|23705068|44224|Discussion|0:0|Major defects in lysosome formation would also be inconsistent with our genetic suppression data and previous studies on GlcCer by others (Entchev et al., 2008; van der Poel et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_297|23705068|55482|Materials and methods|0:0|cgt-3(RNAi) and let-363(RNAi) constructs were made as described (Marza et al., 2009; Honjoh et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_312|23705068|57260|Materials and methods|0:0|In our experiments, the usage of the heterozygous elo-5(-) nprl-3(ku540)/nT1[qIs51] animals for the RNAi knockdown experiment allowed us to exclude the potential negative effect from RNAi treatment of TORC1 components and TORC1 target genes themselves.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_183|23705068|39744|Discussion|0:0|There are several reported leucine-sensing mechanisms, based on studies using tissue culture cells (Bonfils et al., 2012; Duran et al., 2012; Han et al., 2012; Zoncu et al., 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_304|23705068|56415|Materials and methods|0:0|Feeding RNAi analysis of TORC1 components and downstream targets|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_168|23705068|27339|#section_info|0:0|To further examine whether the rescuing effect of nprl-3(ku540) on elo-5(-) L1 arrest required the canonical activity of TORC1, we used RNAi to knock down C. elegans orthologs of elf4E (ife-2) and p70S6K(rsks-1), two well-known downstream targets of TORC1 (Long et al., 2002; Syntichaki et al., 2007; Anjum and Blenis, 2008; Sheaffer et al., 2008).|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
0.81	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	23705068_177|23705068|38632|Discussion|0:0|Both ceramide and TORC1 have been individually implicated for roles in stress response, apoptosis, cancers, and other cellular processes by studies in C. elegans and mammals (Hannun and Obeid, 2008; Hansen et al., 2008; He and Klionsky, 2009; Howell and Manning, 2011; Laplante and Sabatini, 2012; Menuz et al., 2009; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	23705068_25|23705068|3334|Introduction|0:0|The target of rapamycin (TOR) complexes (TORC1 and TORC2) are known to function in sensing various nutrient signals (Ma and Blenis, 2009; Laplante and Sabatini, 2012; Zoncu et al., 2012), and their roles are connected to growth, metabolism, stress responses, and cancers (Hansen et al., 2008; He and Klionsky, 2009; Howell and Manning, 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	23705068_30|23705068|4417|Introduction|0:0|An insulin/IGF-1 receptor signaling (IIS) pathway plays a critical role in the induction of L1 diapause and survival of the developmentally arrested animals (Gems et al., 1998; Baugh and Sternberg, 2006; Kniazeva et al., 2008; Lee and Ashrafi, 2008; Jones et al., 2009; Soukas et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	23705068_31|23705068|4417|Introduction|0:0|Moreover, TOR complexes have also been indicated to play prominent roles in regulating postembryonic growth and lifespan in C. elegans (Vellai et al., 2003; Syntichaki et al., 2007; Hansen et al., 2008; Honjoh et al., 2009; Lucanic et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_185|23705068|40853|Discussion|0:0|In C. elegans, both the IIS and DAF-7/TGF-beta pathways have been shown to play critical roles in the regulation of postembryonic growth and development in response to nutrient/food availability (Baugh and Sternberg, 2006; Mukhopadhyay and Tissenbaum, 2007; Fielenbach and Antebi, 2008; Lee and Ashrafi, 2008; Jones et al., 2009; Soukas et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	23705068_307|23705068|56480|Materials and methods|0:0|Furthermore, results from those references and our experiments have shown RNAi feeding of these genes did not reproduce the strong larval lethal phenotype (Hansen et al., 2007; Syntichaki et al., 2007; Lemire et al., 2009; Ching et al., 2010; Polley and Fay, 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_166|23705068|33611|Results|0:0|Both Rap-1 and Raptor proteins are highly conserved in C. elegans (encoded by rap-1 and daf-15; Long et al., 2002; Pellis-van Berkel et al., 2005).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_211|23705068|44224|Discussion|0:0|By examining lysosomal markers LMP-1::GFP (Artal-Sanz et al., 2006; O'Rourke et al., 2009; Rabbitts et al., 2008), GLO-1::GFP (Schroeder et al., 2007; Zhang et al., 2010), and Neutral red (Long et al., 2002), we did not observe obvious defects in lysosome formation in elo-5(-) mutants (Figure 4:figure supplements 4 and 5).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	23705068_195|23705068|41772|Discussion|0:0|NPRL2 (human ortholog of NPR2) and DEPDC5 (human ortholog of IML1) have been reported to function as tumor suppressors (Merrill et al., 1997; Li et al., 2004; Neklesa and Davis, 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_197|23705068|41772|Discussion|0:0|Second, a role for GlcCer in nutrient sensing is consistent with studies showing that ceramide and sphingolipids play roles in cell signaling and growth control in both invertebrates and mammals (Deng et al., 2008; Hannun and Obeid, 2008; Menuz et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_213|23705068|44224|Discussion|0:0|One possible mechanism is that d17iso-GlcCer acts through the V-ATPase pathway, since the lysosomal V-ATPase has been shown to be stimulated by GlcCer and to play an essential role in TORC1 activation in studies using tissue culture cells (van der Poel et al., 2011; Zoncu et al., 2011; Bar-Peled et al., 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_38|23705068|6227|Introduction|0:0|Further genetic analysis suggested that this developmental arrest is independent of the IIS pathway (Kniazeva et al., 2004, 2008).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_212|23705068|44224|Discussion|0:0|Major defects in lysosome formation would also be inconsistent with our genetic suppression data and previous studies on GlcCer by others (Entchev et al., 2008; van der Poel et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_297|23705068|55482|Materials and methods|0:0|cgt-3(RNAi) and let-363(RNAi) constructs were made as described (Marza et al., 2009; Honjoh et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_312|23705068|57260|Materials and methods|0:0|In our experiments, the usage of the heterozygous elo-5(-) nprl-3(ku540)/nT1[qIs51] animals for the RNAi knockdown experiment allowed us to exclude the potential negative effect from RNAi treatment of TORC1 components and TORC1 target genes themselves.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_183|23705068|39744|Discussion|0:0|There are several reported leucine-sensing mechanisms, based on studies using tissue culture cells (Bonfils et al., 2012; Duran et al., 2012; Han et al., 2012; Zoncu et al., 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_304|23705068|56415|Materials and methods|0:0|Feeding RNAi analysis of TORC1 components and downstream targets|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_169|23705068|27339|#section_info|0:0|To further examine whether the rescuing effect of nprl-3(ku540) on elo-5(-) L1 arrest required the canonical activity of TORC1, we used RNAi to knock down C. elegans orthologs of elf4E (ife-2) and p70S6K(rsks-1), two well-known downstream targets of TORC1 (Long et al., 2002; Syntichaki et al., 2007; Anjum and Blenis, 2008; Sheaffer et al., 2008).|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
0.81	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	23705068_177|23705068|38632|Discussion|0:0|Both ceramide and TORC1 have been individually implicated for roles in stress response, apoptosis, cancers, and other cellular processes by studies in C. elegans and mammals (Hannun and Obeid, 2008; Hansen et al., 2008; He and Klionsky, 2009; Howell and Manning, 2011; Laplante and Sabatini, 2012; Menuz et al., 2009; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	23705068_25|23705068|3334|Introduction|0:0|The target of rapamycin (TOR) complexes (TORC1 and TORC2) are known to function in sensing various nutrient signals (Ma and Blenis, 2009; Laplante and Sabatini, 2012; Zoncu et al., 2012), and their roles are connected to growth, metabolism, stress responses, and cancers (Hansen et al., 2008; He and Klionsky, 2009; Howell and Manning, 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	23705068_30|23705068|4417|Introduction|0:0|An insulin/IGF-1 receptor signaling (IIS) pathway plays a critical role in the induction of L1 diapause and survival of the developmentally arrested animals (Gems et al., 1998; Baugh and Sternberg, 2006; Kniazeva et al., 2008; Lee and Ashrafi, 2008; Jones et al., 2009; Soukas et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	23705068_31|23705068|4417|Introduction|0:0|Moreover, TOR complexes have also been indicated to play prominent roles in regulating postembryonic growth and lifespan in C. elegans (Vellai et al., 2003; Syntichaki et al., 2007; Hansen et al., 2008; Honjoh et al., 2009; Lucanic et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	23705068_185|23705068|40853|Discussion|0:0|In C. elegans, both the IIS and DAF-7/TGF-beta pathways have been shown to play critical roles in the regulation of postembryonic growth and development in response to nutrient/food availability (Baugh and Sternberg, 2006; Mukhopadhyay and Tissenbaum, 2007; Fielenbach and Antebi, 2008; Lee and Ashrafi, 2008; Jones et al., 2009; Soukas et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	23705068_307|23705068|56480|Materials and methods|0:0|Furthermore, results from those references and our experiments have shown RNAi feeding of these genes did not reproduce the strong larval lethal phenotype (Hansen et al., 2007; Syntichaki et al., 2007; Lemire et al., 2009; Ching et al., 2010; Polley and Fay, 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_166|23705068|33611|Results|0:0|Both Rap-1 and Raptor proteins are highly conserved in C. elegans (encoded by rap-1 and daf-15; Long et al., 2002; Pellis-van Berkel et al., 2005).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_211|23705068|44224|Discussion|0:0|By examining lysosomal markers LMP-1::GFP (Artal-Sanz et al., 2006; O'Rourke et al., 2009; Rabbitts et al., 2008), GLO-1::GFP (Schroeder et al., 2007; Zhang et al., 2010), and Neutral red (Long et al., 2002), we did not observe obvious defects in lysosome formation in elo-5(-) mutants (Figure 4:figure supplements 4 and 5).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	23705068_195|23705068|41772|Discussion|0:0|NPRL2 (human ortholog of NPR2) and DEPDC5 (human ortholog of IML1) have been reported to function as tumor suppressors (Merrill et al., 1997; Li et al., 2004; Neklesa and Davis, 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_197|23705068|41772|Discussion|0:0|Second, a role for GlcCer in nutrient sensing is consistent with studies showing that ceramide and sphingolipids play roles in cell signaling and growth control in both invertebrates and mammals (Deng et al., 2008; Hannun and Obeid, 2008; Menuz et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_213|23705068|44224|Discussion|0:0|One possible mechanism is that d17iso-GlcCer acts through the V-ATPase pathway, since the lysosomal V-ATPase has been shown to be stimulated by GlcCer and to play an essential role in TORC1 activation in studies using tissue culture cells (van der Poel et al., 2011; Zoncu et al., 2011; Bar-Peled et al., 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_38|23705068|6227|Introduction|0:0|Further genetic analysis suggested that this developmental arrest is independent of the IIS pathway (Kniazeva et al., 2004, 2008).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_212|23705068|44224|Discussion|0:0|Major defects in lysosome formation would also be inconsistent with our genetic suppression data and previous studies on GlcCer by others (Entchev et al., 2008; van der Poel et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_297|23705068|55482|Materials and methods|0:0|cgt-3(RNAi) and let-363(RNAi) constructs were made as described (Marza et al., 2009; Honjoh et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_312|23705068|57260|Materials and methods|0:0|In our experiments, the usage of the heterozygous elo-5(-) nprl-3(ku540)/nT1[qIs51] animals for the RNAi knockdown experiment allowed us to exclude the potential negative effect from RNAi treatment of TORC1 components and TORC1 target genes themselves.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_183|23705068|39744|Discussion|0:0|There are several reported leucine-sensing mechanisms, based on studies using tissue culture cells (Bonfils et al., 2012; Duran et al., 2012; Han et al., 2012; Zoncu et al., 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_304|23705068|56415|Materials and methods|0:0|Feeding RNAi analysis of TORC1 components and downstream targets|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_170|23705068|27339|#section_info|0:0|Taken together, these results indicate that TORC1 acts downstream of d17iso-GlcCer and is negatively regulated by NPRL-3.|#main_body|GO:0032007|negative regulation of TOR signaling cascade|#go_definition|NONE|GOA|nprl-3(185331)|#gene_synonym
0.63	23705068_106|23705068|19337|Results|0:0|Taken together, our biochemical and genetic data indicate that ku540 bypasses the requirement of mmBCFAs and d17iso-GlcCer in development and does so by modifying a regulatory function downstream of d17iso-GlcCer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_171|23705068|27339|#section_info|0:0|Taken together, these results indicate that TORC1 acts downstream of d17iso-GlcCer and is negatively regulated by NPRL-3.|#main_body|GO:0032007|negative regulation of TOR signaling cascade|#go_definition|NONE|GOA|WBGene00018072(185331)|#gene_synonym
0.63	23705068_106|23705068|19337|Results|0:0|Taken together, our biochemical and genetic data indicate that ku540 bypasses the requirement of mmBCFAs and d17iso-GlcCer in development and does so by modifying a regulatory function downstream of d17iso-GlcCer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_162|23705068|27339|#section_info|0:0|We found that elo-5(-) nprl-3(ku540) animals treated with ife-2(RNAi) or rsks-1(RNAi), with or without C17ISO supplement, yielded results similar to those obtained with raga-1(RNAi) and rheb-1(RNAi) (Table 1). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|ife-2(180393)|#gene_synonym
0.71	23705068_296|23705068|55482|Materials and methods|0:0|All RNAi by feeding, except cgt-3(RNAi) and let-363(RNAi), used bacterial clones from the MRC RNAi library (Kamath et al., 2003) or the ORF-RNAi Library (Open Biosystems) (Figures 1-3).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_238|23705068|48274|Materials and methods|0:0|Using RNAi.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_312|23705068|57260|Materials and methods|0:0|In our experiments, the usage of the heterozygous elo-5(-) nprl-3(ku540)/nT1[qIs51] animals for the RNAi knockdown experiment allowed us to exclude the potential negative effect from RNAi treatment of TORC1 components and TORC1 target genes themselves.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_132|23705068|25881|Results|0:0|Without C17ISO supplementation, RNAi knockdown of multiple TORC1 components reverted elo-5(-);nprl-3(ku540) animals to larval arrest.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_172|23705068|27339|#section_info|0:0|We found that elo-5(-) nprl-3(ku540) animals treated with ife-2(RNAi) or rsks-1(RNAi), with or without C17ISO supplement, yielded results similar to those obtained with raga-1(RNAi) and rheb-1(RNAi) (Table 1). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|rsks-1(176554)|#gene_synonym
0.71	23705068_296|23705068|55482|Materials and methods|0:0|All RNAi by feeding, except cgt-3(RNAi) and let-363(RNAi), used bacterial clones from the MRC RNAi library (Kamath et al., 2003) or the ORF-RNAi Library (Open Biosystems) (Figures 1-3).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	23705068_238|23705068|48274|Materials and methods|0:0|Using RNAi.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_137|23705068|28020|Results|0:0|The defects caused by feeding RNAi of let-363/TOR (Long et al., 2002) are more severe than that by feeding RNAi of other TORC1 components, described above.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_312|23705068|57260|Materials and methods|0:0|In our experiments, the usage of the heterozygous elo-5(-) nprl-3(ku540)/nT1[qIs51] animals for the RNAi knockdown experiment allowed us to exclude the potential negative effect from RNAi treatment of TORC1 components and TORC1 target genes themselves.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_132|23705068|25881|Results|0:0|Without C17ISO supplementation, RNAi knockdown of multiple TORC1 components reverted elo-5(-);nprl-3(ku540) animals to larval arrest.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_173|23705068|29025|#section_info|0:0|FIB-1 localization in the nucleoli is largely abolished in elo-5(-) animals and restored by the nprl-3(-) mutation (the percentages of condensed nucleoli localization for the three genotypes from top to bottom are 95% [n=42], 24% [n=112] and 93% [n=68]).|#fig_caption|GO:0032008|positive regulation of TOR signaling cascade|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
23705068_174|23705068|29025|#section_info|0:0|In wild-type animals, FIB-1 is highly expressed and localized in the nucleolus, where it methylates pre-rRNAs during ribosome maturation, but the expression is decreased and no longer localized to the nucleolus in let-363/TOR(-) animals (Sheaffer et al., 2008).|#fig_caption|GO:0032008|positive regulation of TOR signaling cascade|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
23705068_175|23705068|29025|#section_info|0:0|In wild-type animals, FIB-1 is highly expressed and localized in the nucleolus, where it methylates pre-rRNAs during ribosome maturation, but the expression is decreased and no longer localized to the nucleolus in let-363/TOR(-) animals (Sheaffer et al., 2008).|#fig_caption|GO:0032007|negative regulation of TOR signaling cascade|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_176|23705068|29025|#section_info|0:0|In wild-type animals, FIB-1 is highly expressed and localized in the nucleolus, where it methylates pre-rRNAs during ribosome maturation, but the expression is decreased and no longer localized to the nucleolus in let-363/TOR(-) animals (Sheaffer et al., 2008).|#fig_caption|GO:0032007|negative regulation of TOR signaling cascade|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
##EndOfRet##
23705068_177|23705068|29025|#section_info|0:0|In wild-type animals, FIB-1 is highly expressed and localized in the nucleolus, where it methylates pre-rRNAs during ribosome maturation, but the expression is decreased and no longer localized to the nucleolus in let-363/TOR(-) animals (Sheaffer et al., 2008).|#fig_caption|GO:0005730|nucleolus|#go_definition|IDA|GOA|fib-1(179999)|#gene_synonym
##EndOfRet##
23705068_178|23705068|29025|#section_info|0:0|In wild-type animals, FIB-1 is highly expressed and localized in the nucleolus, where it methylates pre-rRNAs during ribosome maturation, but the expression is decreased and no longer localized to the nucleolus in let-363/TOR(-) animals (Sheaffer et al., 2008).|#fig_caption|GO:0005730|nucleolus|#go_definition|IDA|GOA|WBGene00001423(179999)|#gene_synonym
##EndOfRet##
23705068_179|23705068|30746|#section_info|0:0|While 1 mM C17ISO could suppress the L1 arrest of elo-5(|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
23705068_180|23705068|30746|#section_info|0:0|While 1 mM C17ISO could suppress the L1 arrest of elo-5(|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
23705068_181|23705068|31057|#section_info|0:0|Mutation in none of these negative regulators of the daf-7 pathway permitted the elo-5(RNAi)-treated animals to bypass L1 arrest, suggesting that the TGF-beta pathway does not act downstream of mmBCFAs.|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_182|23705068|31057|#section_info|0:0|Mutation in none of these negative regulators of the daf-7 pathway permitted the elo-5(RNAi)-treated animals to bypass L1 arrest, suggesting that the TGF-beta pathway does not act downstream of mmBCFAs.|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_183|23705068|31057|#section_info|0:0|elo-5(RNAi) enhanced the constitutive dauer formation phenotype of a daf-7(-) mutant.|#fig_caption|GO:0061067|negative regulation of dauer larval development|#go_definition|IMP|GOA|daf-7(175237)|#gene_synonym
0.63	23705068_384|23705068|64071|Additional files|0:0|Two pleiotropic classes of daf-2 mutation affect larval arrest, adult behavior, reproduction and longevity in Caenorhabditis elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_383|23705068|64006|Additional files|0:0|C. elegans dauer formation and the molecular basis of plasticity|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_184|23705068|31057|#section_info|0:0|elo-5(RNAi) enhanced the constitutive dauer formation phenotype of a daf-7(-) mutant.|#fig_caption|GO:0061067|negative regulation of dauer larval development|#go_definition|IMP|GOA|WBGene00000903(175237)|#gene_synonym
0.63	23705068_384|23705068|64071|Additional files|0:0|Two pleiotropic classes of daf-2 mutation affect larval arrest, adult behavior, reproduction and longevity in Caenorhabditis elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_383|23705068|64006|Additional files|0:0|C. elegans dauer formation and the molecular basis of plasticity|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_185|23705068|31057|#section_info|0:0|elo-5(RNAi) enhanced the constitutive dauer formation phenotype of a daf-7(-) mutant.|#fig_caption|GO:0061067|negative regulation of dauer larval development|#go_definition|IGI|GOA|elo-5(177320)|#gene_synonym
0.63	23705068_384|23705068|64071|Additional files|0:0|Two pleiotropic classes of daf-2 mutation affect larval arrest, adult behavior, reproduction and longevity in Caenorhabditis elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_383|23705068|64006|Additional files|0:0|C. elegans dauer formation and the molecular basis of plasticity|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_186|23705068|31057|#section_info|0:0|elo-5(RNAi) enhanced the constitutive dauer formation phenotype of a daf-7(-) mutant.|#fig_caption|GO:0061067|negative regulation of dauer larval development|#go_definition|IGI|GOA|WBGene00001243(177320)|#gene_synonym
0.63	23705068_384|23705068|64071|Additional files|0:0|Two pleiotropic classes of daf-2 mutation affect larval arrest, adult behavior, reproduction and longevity in Caenorhabditis elegans|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_383|23705068|64006|Additional files|0:0|C. elegans dauer formation and the molecular basis of plasticity|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_187|23705068|31057|#section_info|0:0|Neither C17ISO nor d17iso-SPA could suppress the constitutive dauer formation of daf-7(-), suggesting that DAF-7/TGF-beta does not act upstream of mmBCFAs or d17iso-sphingolipid. |#fig_caption|GO:0061067|negative regulation of dauer larval development|#go_definition|IMP|GOA|daf-7(175237)|#gene_synonym
##EndOfRet##
23705068_188|23705068|31057|#section_info|0:0|Neither C17ISO nor d17iso-SPA could suppress the constitutive dauer formation of daf-7(-), suggesting that DAF-7/TGF-beta does not act upstream of mmBCFAs or d17iso-sphingolipid. |#fig_caption|GO:0061067|negative regulation of dauer larval development|#go_definition|IMP|GOA|WBGene00000903(175237)|#gene_synonym
##EndOfRet##
23705068_189|23705068|31057|#section_info|0:0|Neither C17ISO nor d17iso-SPA permits asna-1(-) animals to bypass L1 arrest.|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|asna-1(176254)|#gene_synonym
##EndOfRet##
23705068_190|23705068|31057|#section_info|0:0|Neither C17ISO nor d17iso-SPA permits asna-1(-) animals to bypass L1 arrest.|#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00014025(176254)|#gene_synonym
##EndOfRet##
23705068_191|23705068|32533|#section_info|0:0|Both LMP-1::GFP (A-D) and GLO-1::GFP are lysosomal markers in C. elegans.|#fig_caption|GO:0005764|lysosome|#go_definition|IDA|GOA|lmp-1(180912)|#gene_synonym
0.73	23705068_223|23705068|46470|Materials and methods|0:0|(q782)qIs48], let-363 (ok3018), pwIs50[lmp-1::GFP + Cbr-unc-119(+)], hjIs9 [ges-1p::glo-1::GFP + unc-119(+)].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_192|23705068|32533|#section_info|0:0|Both LMP-1::GFP (A-D) and GLO-1::GFP are lysosomal markers in C. elegans.|#fig_caption|GO:0005764|lysosome|#go_definition|IDA|GOA|WBGene00003053(180912)|#gene_synonym
0.73	23705068_223|23705068|46470|Materials and methods|0:0|(q782)qIs48], let-363 (ok3018), pwIs50[lmp-1::GFP + Cbr-unc-119(+)], hjIs9 [ges-1p::glo-1::GFP + unc-119(+)].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_193|23705068|32533|#section_info|0:0|Both LMP-1::GFP (A-D) and GLO-1::GFP are lysosomal markers in C. elegans.|#fig_caption|GO:0005764|lysosome|#go_definition|IDA|GOA|glo-1(3565633)|#gene_synonym
0.73	23705068_223|23705068|46470|Materials and methods|0:0|(q782)qIs48], let-363 (ok3018), pwIs50[lmp-1::GFP + Cbr-unc-119(+)], hjIs9 [ges-1p::glo-1::GFP + unc-119(+)].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_194|23705068|32533|#section_info|0:0|Both LMP-1::GFP (A-D) and GLO-1::GFP are lysosomal markers in C. elegans.|#fig_caption|GO:0005764|lysosome|#go_definition|IDA|GOA|WBGene00011083(3565633)|#gene_synonym
0.73	23705068_223|23705068|46470|Materials and methods|0:0|(q782)qIs48], let-363 (ok3018), pwIs50[lmp-1::GFP + Cbr-unc-119(+)], hjIs9 [ges-1p::glo-1::GFP + unc-119(+)].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_195|23705068|32984|#section_info|0:0|(A-D) let-363 homozygous L3 animals have increased size and intensity of Neutral red stained lysosomes (D) compared to the heterozygous control (B). |#fig_caption|GO:0007040|lysosome organization|#go_definition|IMP|GOA|let-363(172167)|#gene_synonym
##EndOfRet##
23705068_196|23705068|32984|#section_info|0:0|(A-D) let-363 homozygous L3 animals have increased size and intensity of Neutral red stained lysosomes (D) compared to the heterozygous control (B). |#fig_caption|GO:0007040|lysosome organization|#go_definition|IMP|GOA|WBGene00002583(172167)|#gene_synonym
##EndOfRet##
23705068_197|23705068|32984|#section_info|0:0|(E-H) elo-5 homozygous L1 arrested animals show similar Neutral red intensity and staining pattern (H) when compared to the heterozygous control (F). |#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
23705068_198|23705068|32984|#section_info|0:0|(E-H) elo-5 homozygous L1 arrested animals show similar Neutral red intensity and staining pattern (H) when compared to the heterozygous control (F). |#fig_caption|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
23705068_199|23705068|33611|#section_info|0:0|If d17iso-GlcCer mainly acts through TORC1 for the growth regulation function, constitutive activation of TORC1 should be sufficient to overcome the L1 arrest of elo-5(-) animals, mimicking the effect of nprl-3(ku540).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.67	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_127|23705068|24749|Results|0:0|Intact TORC1 function is necessary for mmBCFA-mediated growth regulation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_141|23705068|28954|Results|0:0|TORC1 activation is sufficient for mmBCFAs-mediated growth regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_217|23705068|45808|Discussion|0:0|Therefore, the only essential biochemical role of d17iso-GlcCer might be to activate TORC1 or repress NPRL-3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_206|23705068|44187|Discussion|0:0|Activation of TORC1 by d17iso-GlcCer|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_200|23705068|33611|#section_info|0:0|If d17iso-GlcCer mainly acts through TORC1 for the growth regulation function, constitutive activation of TORC1 should be sufficient to overcome the L1 arrest of elo-5(-) animals, mimicking the effect of nprl-3(ku540).|#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.67	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_127|23705068|24749|Results|0:0|Intact TORC1 function is necessary for mmBCFA-mediated growth regulation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_141|23705068|28954|Results|0:0|TORC1 activation is sufficient for mmBCFAs-mediated growth regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_217|23705068|45808|Discussion|0:0|Therefore, the only essential biochemical role of d17iso-GlcCer might be to activate TORC1 or repress NPRL-3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_206|23705068|44187|Discussion|0:0|Activation of TORC1 by d17iso-GlcCer|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_201|23705068|33611|#section_info|0:0|If d17iso-GlcCer mainly acts through TORC1 for the growth regulation function, constitutive activation of TORC1 should be sufficient to overcome the L1 arrest of elo-5(-) animals, mimicking the effect of nprl-3(ku540).|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
0.67	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_127|23705068|24749|Results|0:0|Intact TORC1 function is necessary for mmBCFA-mediated growth regulation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_141|23705068|28954|Results|0:0|TORC1 activation is sufficient for mmBCFAs-mediated growth regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_217|23705068|45808|Discussion|0:0|Therefore, the only essential biochemical role of d17iso-GlcCer might be to activate TORC1 or repress NPRL-3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_206|23705068|44187|Discussion|0:0|Activation of TORC1 by d17iso-GlcCer|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_202|23705068|33611|#section_info|0:0|If d17iso-GlcCer mainly acts through TORC1 for the growth regulation function, constitutive activation of TORC1 should be sufficient to overcome the L1 arrest of elo-5(-) animals, mimicking the effect of nprl-3(ku540).|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
0.67	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_127|23705068|24749|Results|0:0|Intact TORC1 function is necessary for mmBCFA-mediated growth regulation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	23705068_141|23705068|28954|Results|0:0|TORC1 activation is sufficient for mmBCFAs-mediated growth regulation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_217|23705068|45808|Discussion|0:0|Therefore, the only essential biochemical role of d17iso-GlcCer might be to activate TORC1 or repress NPRL-3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_206|23705068|44187|Discussion|0:0|Activation of TORC1 by d17iso-GlcCer|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_203|23705068|33611|#section_info|0:0|We fused a 22-amino acid fragment of the C-terminal end of rap-1 to the C-terminal end of daf-15 and named it daf-15::rap-1(22). We found that 56.0% of elo-5(-) mutants carrying daf-15::rap-1(22) bypassed L1 arrest and reached L3 to adult stage (n = 161; normalized against elo-5(-/+) heterozygotes containing the transgene; Figure 4A,B). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|daf-15(177770)|#gene_synonym
##EndOfRet##
23705068_204|23705068|33611|#section_info|0:0|We fused a 22-amino acid fragment of the C-terminal end of rap-1 to the C-terminal end of daf-15 and named it daf-15::rap-1(22). We found that 56.0% of elo-5(-) mutants carrying daf-15::rap-1(22) bypassed L1 arrest and reached L3 to adult stage (n = 161; normalized against elo-5(-/+) heterozygotes containing the transgene; Figure 4A,B). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00000911(177770)|#gene_synonym
##EndOfRet##
23705068_205|23705068|33611|#section_info|0:0|We fused a 22-amino acid fragment of the C-terminal end of rap-1 to the C-terminal end of daf-15 and named it daf-15::rap-1(22). We found that 56.0% of elo-5(-) mutants carrying daf-15::rap-1(22) bypassed L1 arrest and reached L3 to adult stage (n = 161; normalized against elo-5(-/+) heterozygotes containing the transgene; Figure 4A,B). |#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
23705068_206|23705068|33611|#section_info|0:0|We fused a 22-amino acid fragment of the C-terminal end of rap-1 to the C-terminal end of daf-15 and named it daf-15::rap-1(22). We found that 56.0% of elo-5(-) mutants carrying daf-15::rap-1(22) bypassed L1 arrest and reached L3 to adult stage (n = 161; normalized against elo-5(-/+) heterozygotes containing the transgene; Figure 4A,B). |#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
23705068_207|23705068|34752|#section_info|0:0|4% of elo-5(-) mutants containing the raga-1Q63L transgene bypassed L1 arrest and reached L3-L4 stage (n = 248, p=1.0 x 10-6; normalized against elo-5(-/+) heterozygotes containing the transgene; Figure 4A) while none of elo-5(-) mutants without this transgene did (n = 136). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|raga-1(174726)|#gene_synonym
##EndOfRet##
23705068_208|23705068|34752|#section_info|0:0|4% of elo-5(-) mutants containing the raga-1Q63L transgene bypassed L1 arrest and reached L3-L4 stage (n = 248, p=1.0 x 10-6; normalized against elo-5(-/+) heterozygotes containing the transgene; Figure 4A) while none of elo-5(-) mutants without this transgene did (n = 136). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00006414(174726)|#gene_synonym
##EndOfRet##
23705068_209|23705068|34752|#section_info|0:0|4% of elo-5(-) mutants containing the raga-1Q63L transgene bypassed L1 arrest and reached L3-L4 stage (n = 248, p=1.0 x 10-6; normalized against elo-5(-/+) heterozygotes containing the transgene; Figure 4A) while none of elo-5(-) mutants without this transgene did (n = 136). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
23705068_210|23705068|34752|#section_info|0:0|4% of elo-5(-) mutants containing the raga-1Q63L transgene bypassed L1 arrest and reached L3-L4 stage (n = 248, p=1.0 x 10-6; normalized against elo-5(-/+) heterozygotes containing the transgene; Figure 4A) while none of elo-5(-) mutants without this transgene did (n = 136). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
##EndOfRet##
23705068_211|23705068|34752|#section_info|0:0|Finally, we also tested a third TORC1-activating transgene, rheb-1Q71LQ72D, and found that it also permitted 41.4% of elo-5(-) animals to grow beyond the L1 stage (n = 169; normalized against elo-5(-/+) heterozygotes containing the transgene; Figure 4A). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.61	23705068_291|23705068|54380|Materials and methods|0:0|For Figure 2I, because the control cgt-3(-);cgt-1(-) animals were fully arrested at L1 and were derived from cgt-3(-);cgt-1(-)/nT1[qIs51] heterozygotes, we had to use heterozygous cgt-3(-);elo-5(-) nprl-3(ku540)/nT1[qIs51];cgt-1(-)/nT1[qIs51] P0 animals to generate cgt-1(-);cgt-3(-);elo-5(-) nprl-3(ku540) homozygous animals to generate comparable data.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_212|23705068|34752|#section_info|0:0|Finally, we also tested a third TORC1-activating transgene, rheb-1Q71LQ72D, and found that it also permitted 41.4% of elo-5(-) animals to grow beyond the L1 stage (n = 169; normalized against elo-5(-/+) heterozygotes containing the transgene; Figure 4A). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.61	23705068_291|23705068|54380|Materials and methods|0:0|For Figure 2I, because the control cgt-3(-);cgt-1(-) animals were fully arrested at L1 and were derived from cgt-3(-);cgt-1(-)/nT1[qIs51] heterozygotes, we had to use heterozygous cgt-3(-);elo-5(-) nprl-3(ku540)/nT1[qIs51];cgt-1(-)/nT1[qIs51] P0 animals to generate cgt-1(-);cgt-3(-);elo-5(-) nprl-3(ku540) homozygous animals to generate comparable data.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_213|23705068|34752|#section_info|0:0|Finally, we also tested a third TORC1-activating transgene, rheb-1Q71LQ72D, and found that it also permitted 41.4% of elo-5(-) animals to grow beyond the L1 stage (n = 169; normalized against elo-5(-/+) heterozygotes containing the transgene; Figure 4A). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|rheb-1(176327)|#gene_synonym
0.61	23705068_291|23705068|54380|Materials and methods|0:0|For Figure 2I, because the control cgt-3(-);cgt-1(-) animals were fully arrested at L1 and were derived from cgt-3(-);cgt-1(-)/nT1[qIs51] heterozygotes, we had to use heterozygous cgt-3(-);elo-5(-) nprl-3(ku540)/nT1[qIs51];cgt-1(-)/nT1[qIs51] P0 animals to generate cgt-1(-);cgt-3(-);elo-5(-) nprl-3(ku540) homozygous animals to generate comparable data.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_214|23705068|34752|#section_info|0:0|Finally, we also tested a third TORC1-activating transgene, rheb-1Q71LQ72D, and found that it also permitted 41.4% of elo-5(-) animals to grow beyond the L1 stage (n = 169; normalized against elo-5(-/+) heterozygotes containing the transgene; Figure 4A). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00010038(176327)|#gene_synonym
0.61	23705068_291|23705068|54380|Materials and methods|0:0|For Figure 2I, because the control cgt-3(-);cgt-1(-) animals were fully arrested at L1 and were derived from cgt-3(-);cgt-1(-)/nT1[qIs51] heterozygotes, we had to use heterozygous cgt-3(-);elo-5(-) nprl-3(ku540)/nT1[qIs51];cgt-1(-)/nT1[qIs51] P0 animals to generate cgt-1(-);cgt-3(-);elo-5(-) nprl-3(ku540) homozygous animals to generate comparable data.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_215|23705068|34752|#section_info|0:0|These results led to the conclusion that TORC1 acts downstream of d17iso-GlcCer to promote L1 growth and development and that this activity is negatively regulated by NPRL-2/3.|#main_body|GO:0032007|negative regulation of TOR signaling cascade|#go_definition|NONE|GOA|nprl-2(177532)|#gene_synonym
0.65	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_196|23705068|41772|Discussion|0:0|This property is consistent with the role of this complex in repressing TOR-mediated growth regulation that was identified in budding yeast and this study.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_16|23705068|2015|abstract|0:0|TORC1 is well known for its role in sensing amino acids and growth factors, but this is the first time that it has been shown to be involved in detecting lipids.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_106|23705068|19337|Results|0:0|Taken together, our biochemical and genetic data indicate that ku540 bypasses the requirement of mmBCFAs and d17iso-GlcCer in development and does so by modifying a regulatory function downstream of d17iso-GlcCer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_216|23705068|34752|#section_info|0:0|These results led to the conclusion that TORC1 acts downstream of d17iso-GlcCer to promote L1 growth and development and that this activity is negatively regulated by NPRL-2/3.|#main_body|GO:0032007|negative regulation of TOR signaling cascade|#go_definition|NONE|GOA|WBGene00018635(177532)|#gene_synonym
0.65	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_196|23705068|41772|Discussion|0:0|This property is consistent with the role of this complex in repressing TOR-mediated growth regulation that was identified in budding yeast and this study.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_16|23705068|2015|abstract|0:0|TORC1 is well known for its role in sensing amino acids and growth factors, but this is the first time that it has been shown to be involved in detecting lipids.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_106|23705068|19337|Results|0:0|Taken together, our biochemical and genetic data indicate that ku540 bypasses the requirement of mmBCFAs and d17iso-GlcCer in development and does so by modifying a regulatory function downstream of d17iso-GlcCer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_217|23705068|34752|#section_info|0:0|These results led to the conclusion that TORC1 acts downstream of d17iso-GlcCer to promote L1 growth and development and that this activity is negatively regulated by NPRL-2/3.|#main_body|GO:0032007|negative regulation of TOR signaling cascade|#go_definition|NONE|GOA|nprl-3(185331)|#gene_synonym
0.65	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_196|23705068|41772|Discussion|0:0|This property is consistent with the role of this complex in repressing TOR-mediated growth regulation that was identified in budding yeast and this study.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_16|23705068|2015|abstract|0:0|TORC1 is well known for its role in sensing amino acids and growth factors, but this is the first time that it has been shown to be involved in detecting lipids.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_106|23705068|19337|Results|0:0|Taken together, our biochemical and genetic data indicate that ku540 bypasses the requirement of mmBCFAs and d17iso-GlcCer in development and does so by modifying a regulatory function downstream of d17iso-GlcCer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_218|23705068|34752|#section_info|0:0|These results led to the conclusion that TORC1 acts downstream of d17iso-GlcCer to promote L1 growth and development and that this activity is negatively regulated by NPRL-2/3.|#main_body|GO:0032007|negative regulation of TOR signaling cascade|#go_definition|NONE|GOA|WBGene00018072(185331)|#gene_synonym
0.65	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_196|23705068|41772|Discussion|0:0|This property is consistent with the role of this complex in repressing TOR-mediated growth regulation that was identified in budding yeast and this study.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_16|23705068|2015|abstract|0:0|TORC1 is well known for its role in sensing amino acids and growth factors, but this is the first time that it has been shown to be involved in detecting lipids.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_106|23705068|19337|Results|0:0|Taken together, our biochemical and genetic data indicate that ku540 bypasses the requirement of mmBCFAs and d17iso-GlcCer in development and does so by modifying a regulatory function downstream of d17iso-GlcCer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_219|23705068|34752|#section_info|0:0|These results led to the conclusion that TORC1 acts downstream of d17iso-GlcCer to promote L1 growth and development and that this activity is negatively regulated by NPRL-2/3.|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|NONE|GOA|nprl-2(177532)|#gene_synonym
0.65	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_196|23705068|41772|Discussion|0:0|This property is consistent with the role of this complex in repressing TOR-mediated growth regulation that was identified in budding yeast and this study.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_16|23705068|2015|abstract|0:0|TORC1 is well known for its role in sensing amino acids and growth factors, but this is the first time that it has been shown to be involved in detecting lipids.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_106|23705068|19337|Results|0:0|Taken together, our biochemical and genetic data indicate that ku540 bypasses the requirement of mmBCFAs and d17iso-GlcCer in development and does so by modifying a regulatory function downstream of d17iso-GlcCer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_220|23705068|34752|#section_info|0:0|These results led to the conclusion that TORC1 acts downstream of d17iso-GlcCer to promote L1 growth and development and that this activity is negatively regulated by NPRL-2/3.|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|NONE|GOA|WBGene00018635(177532)|#gene_synonym
0.65	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_196|23705068|41772|Discussion|0:0|This property is consistent with the role of this complex in repressing TOR-mediated growth regulation that was identified in budding yeast and this study.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_16|23705068|2015|abstract|0:0|TORC1 is well known for its role in sensing amino acids and growth factors, but this is the first time that it has been shown to be involved in detecting lipids.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_106|23705068|19337|Results|0:0|Taken together, our biochemical and genetic data indicate that ku540 bypasses the requirement of mmBCFAs and d17iso-GlcCer in development and does so by modifying a regulatory function downstream of d17iso-GlcCer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_221|23705068|34752|#section_info|0:0|These results led to the conclusion that TORC1 acts downstream of d17iso-GlcCer to promote L1 growth and development and that this activity is negatively regulated by NPRL-2/3.|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|NONE|GOA|nprl-3(185331)|#gene_synonym
0.65	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_196|23705068|41772|Discussion|0:0|This property is consistent with the role of this complex in repressing TOR-mediated growth regulation that was identified in budding yeast and this study.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_16|23705068|2015|abstract|0:0|TORC1 is well known for its role in sensing amino acids and growth factors, but this is the first time that it has been shown to be involved in detecting lipids.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_106|23705068|19337|Results|0:0|Taken together, our biochemical and genetic data indicate that ku540 bypasses the requirement of mmBCFAs and d17iso-GlcCer in development and does so by modifying a regulatory function downstream of d17iso-GlcCer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_222|23705068|34752|#section_info|0:0|These results led to the conclusion that TORC1 acts downstream of d17iso-GlcCer to promote L1 growth and development and that this activity is negatively regulated by NPRL-2/3.|#main_body|GO:0061064|negative regulation of nematode larval development|#go_definition|NONE|GOA|WBGene00018072(185331)|#gene_synonym
0.65	23705068_18|23705068|2015|abstract|0:0|also show that, in the absence of the lipid, postembryonic growth and development can be initiated by activating TORC1 or inhibiting NPRL-2/3.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_196|23705068|41772|Discussion|0:0|This property is consistent with the role of this complex in repressing TOR-mediated growth regulation that was identified in budding yeast and this study.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_16|23705068|2015|abstract|0:0|TORC1 is well known for its role in sensing amino acids and growth factors, but this is the first time that it has been shown to be involved in detecting lipids.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_106|23705068|19337|Results|0:0|Taken together, our biochemical and genetic data indicate that ku540 bypasses the requirement of mmBCFAs and d17iso-GlcCer in development and does so by modifying a regulatory function downstream of d17iso-GlcCer.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_223|23705068|35797|#section_info|0:0|The fact that elo-5(-);nprl-3(ku540) animals treated with ife-2 RNAi, that targets intestinal but not neuronal expression of the gene (Syntichaki et al., 2007), are L1 arrested (Table 1) also points to the requirement of TORC1 activity in the intestine. |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|ife-2(180393)|#gene_synonym
0.72	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_312|23705068|57260|Materials and methods|0:0|In our experiments, the usage of the heterozygous elo-5(-) nprl-3(ku540)/nT1[qIs51] animals for the RNAi knockdown experiment allowed us to exclude the potential negative effect from RNAi treatment of TORC1 components and TORC1 target genes themselves.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_132|23705068|25881|Results|0:0|Without C17ISO supplementation, RNAi knockdown of multiple TORC1 components reverted elo-5(-);nprl-3(ku540) animals to larval arrest.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_30|23705068|4417|Introduction|0:0|An insulin/IGF-1 receptor signaling (IIS) pathway plays a critical role in the induction of L1 diapause and survival of the developmentally arrested animals (Gems et al., 1998; Baugh and Sternberg, 2006; Kniazeva et al., 2008; Lee and Ashrafi, 2008; Jones et al., 2009; Soukas et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_224|23705068|35797|#section_info|0:0|The fact that elo-5(-);nprl-3(ku540) animals treated with ife-2 RNAi, that targets intestinal but not neuronal expression of the gene (Syntichaki et al., 2007), are L1 arrested (Table 1) also points to the requirement of TORC1 activity in the intestine. |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00002060(180393)|#gene_synonym
0.72	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_312|23705068|57260|Materials and methods|0:0|In our experiments, the usage of the heterozygous elo-5(-) nprl-3(ku540)/nT1[qIs51] animals for the RNAi knockdown experiment allowed us to exclude the potential negative effect from RNAi treatment of TORC1 components and TORC1 target genes themselves.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_132|23705068|25881|Results|0:0|Without C17ISO supplementation, RNAi knockdown of multiple TORC1 components reverted elo-5(-);nprl-3(ku540) animals to larval arrest.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_30|23705068|4417|Introduction|0:0|An insulin/IGF-1 receptor signaling (IIS) pathway plays a critical role in the induction of L1 diapause and survival of the developmentally arrested animals (Gems et al., 1998; Baugh and Sternberg, 2006; Kniazeva et al., 2008; Lee and Ashrafi, 2008; Jones et al., 2009; Soukas et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_225|23705068|35797|#section_info|0:0|To directly evaluate a role of intestinal TORC1 in mmBCFA/d17iso-GlcCer regulated growth, we made a raga-1Q63L TORC1 hyperactivating transgene driven by the intestinal-specific promoter ges-1 (Edgar and McGhee, 1986). We found that elo-5(-) animals containing this transgene bypassed the L1 arrest (37.9%, n = 132, normalized against elo-5(-/+) heterozygotes containing the transgene; Figure 4A). The rescue with the intestinal expression was similar to that by a ubiquitously expressed raga-1Q63L transgene (above). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|raga-1(174726)|#gene_synonym
0.66	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_327|23705068|58434|Materials and methods|0:0|By this method, we exclude the negative effect we observed from constitutively active TORC1 transgenes (daf-15::rap-1(22), raga-1Q63L, ges-1::raga-1Q63L or rheb-1Q71LQ72D) for their rescue effects.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_226|23705068|35797|#section_info|0:0|To directly evaluate a role of intestinal TORC1 in mmBCFA/d17iso-GlcCer regulated growth, we made a raga-1Q63L TORC1 hyperactivating transgene driven by the intestinal-specific promoter ges-1 (Edgar and McGhee, 1986). We found that elo-5(-) animals containing this transgene bypassed the L1 arrest (37.9%, n = 132, normalized against elo-5(-/+) heterozygotes containing the transgene; Figure 4A). The rescue with the intestinal expression was similar to that by a ubiquitously expressed raga-1Q63L transgene (above). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00006414(174726)|#gene_synonym
0.66	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_327|23705068|58434|Materials and methods|0:0|By this method, we exclude the negative effect we observed from constitutively active TORC1 transgenes (daf-15::rap-1(22), raga-1Q63L, ges-1::raga-1Q63L or rheb-1Q71LQ72D) for their rescue effects.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_227|23705068|35797|#section_info|0:0|To directly evaluate a role of intestinal TORC1 in mmBCFA/d17iso-GlcCer regulated growth, we made a raga-1Q63L TORC1 hyperactivating transgene driven by the intestinal-specific promoter ges-1 (Edgar and McGhee, 1986). We found that elo-5(-) animals containing this transgene bypassed the L1 arrest (37.9%, n = 132, normalized against elo-5(-/+) heterozygotes containing the transgene; Figure 4A). The rescue with the intestinal expression was similar to that by a ubiquitously expressed raga-1Q63L transgene (above). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.66	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_327|23705068|58434|Materials and methods|0:0|By this method, we exclude the negative effect we observed from constitutively active TORC1 transgenes (daf-15::rap-1(22), raga-1Q63L, ges-1::raga-1Q63L or rheb-1Q71LQ72D) for their rescue effects.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_228|23705068|35797|#section_info|0:0|To directly evaluate a role of intestinal TORC1 in mmBCFA/d17iso-GlcCer regulated growth, we made a raga-1Q63L TORC1 hyperactivating transgene driven by the intestinal-specific promoter ges-1 (Edgar and McGhee, 1986). We found that elo-5(-) animals containing this transgene bypassed the L1 arrest (37.9%, n = 132, normalized against elo-5(-/+) heterozygotes containing the transgene; Figure 4A). The rescue with the intestinal expression was similar to that by a ubiquitously expressed raga-1Q63L transgene (above). |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.66	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	23705068_327|23705068|58434|Materials and methods|0:0|By this method, we exclude the negative effect we observed from constitutively active TORC1 transgenes (daf-15::rap-1(22), raga-1Q63L, ges-1::raga-1Q63L or rheb-1Q71LQ72D) for their rescue effects.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_229|23705068|35797|#section_info|0:0|The fact that elo-5(-);nprl-3(ku540) animals treated with ife-2 RNAi, that targets intestinal but not neuronal expression of the gene (Syntichaki et al., 2007), are L1 arrested (Table 1) also points to the requirement of TORC1 activity in the intestine. |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|ife-2(180393)|#gene_synonym
0.72	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_312|23705068|57260|Materials and methods|0:0|In our experiments, the usage of the heterozygous elo-5(-) nprl-3(ku540)/nT1[qIs51] animals for the RNAi knockdown experiment allowed us to exclude the potential negative effect from RNAi treatment of TORC1 components and TORC1 target genes themselves.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_132|23705068|25881|Results|0:0|Without C17ISO supplementation, RNAi knockdown of multiple TORC1 components reverted elo-5(-);nprl-3(ku540) animals to larval arrest.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_30|23705068|4417|Introduction|0:0|An insulin/IGF-1 receptor signaling (IIS) pathway plays a critical role in the induction of L1 diapause and survival of the developmentally arrested animals (Gems et al., 1998; Baugh and Sternberg, 2006; Kniazeva et al., 2008; Lee and Ashrafi, 2008; Jones et al., 2009; Soukas et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_230|23705068|35797|#section_info|0:0|The fact that elo-5(-);nprl-3(ku540) animals treated with ife-2 RNAi, that targets intestinal but not neuronal expression of the gene (Syntichaki et al., 2007), are L1 arrested (Table 1) also points to the requirement of TORC1 activity in the intestine. |#main_body|GO:0061063|positive regulation of nematode larval development|#go_definition|IGI|GOA|WBGene00002060(180393)|#gene_synonym
0.72	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_215|23705068|45808|Discussion|0:0|It may be important to point out again that activation of TORC1 bypasses the robust L1 arrest phenotype caused by either mmBCFA or d17iso-GlcCer deficiency.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	23705068_312|23705068|57260|Materials and methods|0:0|In our experiments, the usage of the heterozygous elo-5(-) nprl-3(ku540)/nT1[qIs51] animals for the RNAi knockdown experiment allowed us to exclude the potential negative effect from RNAi treatment of TORC1 components and TORC1 target genes themselves.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_132|23705068|25881|Results|0:0|Without C17ISO supplementation, RNAi knockdown of multiple TORC1 components reverted elo-5(-);nprl-3(ku540) animals to larval arrest.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_30|23705068|4417|Introduction|0:0|An insulin/IGF-1 receptor signaling (IIS) pathway plays a critical role in the induction of L1 diapause and survival of the developmentally arrested animals (Gems et al., 1998; Baugh and Sternberg, 2006; Kniazeva et al., 2008; Lee and Ashrafi, 2008; Jones et al., 2009; Soukas et al., 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_231|23705068|37121|#section_info|0:0|Because the biochemical assay for p70S6K phosphorylation has not been established in C. elegans' TOR-related studies, we adopted the strategy by Sheaffer et al. (2008), where localization of FIB-1, a Box C/D small nucleolar ribonucleoprotein (snoRNP) was used as a marker of TORC1 activation in C. elegans. We found that the nucleolar localized FIB-1 was dramatically reduced in intestinal cells of mmBCFA-deficient [elo-5(RNAi)] animals (Figure 4C).|#main_body|GO:0032008|positive regulation of TOR signaling cascade|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
0.68	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_192|23705068|41772|Discussion|0:0|First, the components of TORC1 are conserved between C. elegans and mammals.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_166|23705068|33611|Results|0:0|Both Rap-1 and Raptor proteins are highly conserved in C. elegans (encoded by rap-1 and daf-15; Long et al., 2002; Pellis-van Berkel et al., 2005).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_28|23705068|4417|Introduction|0:0|In Caenorhabditis elegans, the first larval stage has been established as a model system for the study of animal growth and development in response to food availability.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_193|23705068|41772|Discussion|0:0|The NPRL-3 protein we identified in this pathway is conserved in all eukaryotes, and its negative regulatory role on TOR has been characterized in budding yeast (Neklesa and Davis, 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_213|23705068|44224|Discussion|0:0|One possible mechanism is that d17iso-GlcCer acts through the V-ATPase pathway, since the lysosomal V-ATPase has been shown to be stimulated by GlcCer and to play an essential role in TORC1 activation in studies using tissue culture cells (van der Poel et al., 2011; Zoncu et al., 2011; Bar-Peled et al., 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_232|23705068|37121|#section_info|0:0|Because the biochemical assay for p70S6K phosphorylation has not been established in C. elegans' TOR-related studies, we adopted the strategy by Sheaffer et al. (2008), where localization of FIB-1, a Box C/D small nucleolar ribonucleoprotein (snoRNP) was used as a marker of TORC1 activation in C. elegans. We found that the nucleolar localized FIB-1 was dramatically reduced in intestinal cells of mmBCFA-deficient [elo-5(RNAi)] animals (Figure 4C).|#main_body|GO:0032008|positive regulation of TOR signaling cascade|#go_definition|IMP|GOA|WBGene00001243(177320)|#gene_synonym
0.68	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	23705068_192|23705068|41772|Discussion|0:0|First, the components of TORC1 are conserved between C. elegans and mammals.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_166|23705068|33611|Results|0:0|Both Rap-1 and Raptor proteins are highly conserved in C. elegans (encoded by rap-1 and daf-15; Long et al., 2002; Pellis-van Berkel et al., 2005).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_28|23705068|4417|Introduction|0:0|In Caenorhabditis elegans, the first larval stage has been established as a model system for the study of animal growth and development in response to food availability.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_193|23705068|41772|Discussion|0:0|The NPRL-3 protein we identified in this pathway is conserved in all eukaryotes, and its negative regulatory role on TOR has been characterized in budding yeast (Neklesa and Davis, 2009).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_213|23705068|44224|Discussion|0:0|One possible mechanism is that d17iso-GlcCer acts through the V-ATPase pathway, since the lysosomal V-ATPase has been shown to be stimulated by GlcCer and to play an essential role in TORC1 activation in studies using tissue culture cells (van der Poel et al., 2011; Zoncu et al., 2011; Bar-Peled et al., 2012).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_233|23705068|37121|#section_info|0:0|Because the biochemical assay for p70S6K phosphorylation has not been established in C. elegans' TOR-related studies, we adopted the strategy by Sheaffer et al. (2008), where localization of FIB-1, a Box C/D small nucleolar ribonucleoprotein (snoRNP) was used as a marker of TORC1 activation in C. elegans. We found that the nucleolar localized FIB-1 was dramatically reduced in intestinal cells of mmBCFA-deficient [elo-5(RNAi)] animals (Figure 4C). Furthermore, nprl-3(-) rescued the FIB-1 expression and nucleolar localization in elo-5(-) back to that of wild type (Figure 4C).|#main_body|GO:0032007|negative regulation of TOR signaling cascade|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
0.67	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_234|23705068|37121|#section_info|0:0|Because the biochemical assay for p70S6K phosphorylation has not been established in C. elegans' TOR-related studies, we adopted the strategy by Sheaffer et al. (2008), where localization of FIB-1, a Box C/D small nucleolar ribonucleoprotein (snoRNP) was used as a marker of TORC1 activation in C. elegans. We found that the nucleolar localized FIB-1 was dramatically reduced in intestinal cells of mmBCFA-deficient [elo-5(RNAi)] animals (Figure 4C). Furthermore, nprl-3(-) rescued the FIB-1 expression and nucleolar localization in elo-5(-) back to that of wild type (Figure 4C).|#main_body|GO:0032007|negative regulation of TOR signaling cascade|#go_definition|IGI|GOA|WBGene00018072(185331)|#gene_synonym
0.67	23705068_184|23705068|39744|Discussion|0:0|To test if such a pathway acts in parallel to the mmBCFA/d17iso-GlcCer pathway to promote TORC1 in the C. elegans intestine, we supplemented elo-5(-) animals with a high level of dietary leucine (10 mM) and failed to observe any suppression of the L1 arrest phenotype (Figure 4:figure supplement 2), consistent with the idea that TORC1 activation by mmBCFA/d17iso-GlcCer is essential in the intestine of L1 larvae and cannot be effectively compensated by another leucine/TORC1 mechanism in C. elegans.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_136|23705068|28020|Results|0:0|The let-363/TOR(-) mutations cause late larval arrest and other severe defects (Long et al., 2002), but injection RNAi causes an early embryonic lethal phenotype (Sonnichsen et al., 2005), indicating that LET-363/TOR, a key component of both TORC1 and TORC2, plays critical regulatory roles in a broad range of developmental stages and a maternal effect largely masks its roles in earlier stages, including its likely functions during L1 growth.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_138|23705068|28020|Results|0:0|elo-5(-) nprl-3(-);let-363(RNAi) animals displayed pleiotropic phenotypes that could not be rescued by C17ISO supplement (Table 1), which is consistent with TORC1 acting downstream of ELO-5.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	23705068_311|23705068|57260|Materials and methods|0:0|As reported, RNAi knockdown of TORC1 components and the downstream target genes would affect the normal development of C. elegans (Long et al., 2002; Syntichaki et al., 2007; Zoncu et al., 2011).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
23705068_173|23705068|37121|#section_info|0:0|In wild-type animals, FIB-1 is highly expressed and localized in the nucleolus, where it methylates pre-rRNAs during ribosome maturation, but the expression is decreased and no longer localized to the nucleolus in let-363/TOR(-) animals (Sheaffer et al., 2008).|#main_body|GO:0032008|positive regulation of TOR signaling cascade|#go_definition|IMP|GOA|elo-5(177320)|#gene_synonym
##EndOfRet##
23705068_235|23705068|37121|#section_info|0:0|In wild-type animals, FIB-1 is highly expressed and localized in the nucleolus, where it methylates pre-rRNAs during ribosome maturation, but the expression is decreased and no longer localized to the nucleolus in let-363/TOR(-) animals (Sheaffer et al., 2008).|#main_body|GO:0032007|negative regulation of TOR signaling cascade|#go_definition|IGI|GOA|nprl-3(185331)|#gene_synonym
##EndOfRet##
23705068_236|23705068|37121|#section_info|0:0|In wild-type animals, FIB-1 is highly expressed and localized in the nucleolus, where it methylates pre-rRNAs during ribosome maturation, but the expression is decreased and no longer localized to the nucleolus in let-363/TOR(-) animals (Sheaffer et al., 2008).|#main_body|GO:0005730|nucleolus|#go_definition|IDA|GOA|fib-1(179999)|#gene_synonym
##EndOfRet##
